10525055	19	Lawn RM	The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.	The Journal of clinical investigation	1999	106
11135616	19	Chinetti G	PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.	Nature medicine	2001	166
15326314	19	Bergt C	The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.	Proceedings of the National Academy of Sciences of the United States of America	2004	108
16497665	19	Shao B	Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.	The Journal of biological chemistry	2006	61
18523221	19	Frikke-Schmidt R	Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.	JAMA	2008	78
18617650	19	Murphy AJ	High-density lipoprotein reduces the human monocyte inflammatory response.	Arteriosclerosis, thrombosis, and vascular biology	2008	82
20103563	19	Klaassen CD	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.	Pharmacological reviews	2010	156
20448206	19	Yvan-Charvet L	Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.	Arteriosclerosis, thrombosis, and vascular biology	2010	54
24371263	19	Herman-Edelstein M	Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.	Journal of lipid research	2014	29
24385509	19	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	44
24481950	19	Allahverdian S	Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.	Circulation	2014	49
24647144	19	Shao B	Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.	Circulation research	2014	34
25173105	19	Gharahkhani P	Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma.	Nature genetics	2014	25
25173106	19	Hysi PG	Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma.	Nature genetics	2014	35
25589556	19	Du XM	HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.	Circulation research	2015	37
9295268	24	Allikmets R	Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.	Science	1997	180
9466990	24	Cremers FP	Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR.	Human molecular genetics	1998	121
20711710	24	Tsybovsky Y	The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease.	Advances in experimental medicine and biology	2010	40
21911583	24	Zernant J	Analysis of the ABCA4 gene by next-generation sequencing.	Investigative ophthalmology and visual science	2011	38
23591405	24	Glöckle N	Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies.	European journal of human genetics 	2014	59
23918662	24	Braun TA	Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease.	Human molecular genetics	2013	33
10097139	102	Lammich S	Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.	Proceedings of the National Academy of Sciences of the United States of America	1999	196
12832423	102	Matthews V	Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).	The Journal of biological chemistry	2003	80
15716380	102	Gavert N	L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.	The Journal of cell biology	2005	77
18603587	102	Raucci A	A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).	FASEB journal 	2008	114
18762209	102	Edwards DR	The ADAM metalloproteinases.	Molecular aspects of medicine	2008	240
19726682	102	van Tetering G	Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.	The Journal of biological chemistry	2009	81
23035126	102	Haining EJ	The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.	The Journal of biological chemistry	2012	30
24055016	102	Suh J	ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.	Neuron	2013	33
25150980	102	Shimoda M	Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.	Nature cell biology	2014	24
12642050	197	Ketteler M	Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.	Lancet	2003	124
15375022	197	Moe SM	Pathophysiology of vascular calcification in chronic kidney disease.	Circulation research	2004	79
16567827	197	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	88
17021608	197	Zhou H	Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.	Kidney international	2006	73
18612115	197	Ix JH	Fetuin-A and incident diabetes mellitus in older persons.	JAMA	2008	64
18633113	197	Stefan N	Plasma fetuin-A levels and the risk of type 2 diabetes.	Diabetes	2008	73
22426755	197	Montonen J	Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress.	European journal of nutrition	2013	26
23337953	197	Stefan N	The role of hepatokines in metabolism.	Nature reviews. Endocrinology	2013	33
25711438	197	Kapustin AN	Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.	Circulation research	2015	36
10625301	207	Kim I	Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.	Circulation research	2000	128
10910062	207	Sekulić A	A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.	Cancer research	2000	166
12173037	207	Mitsiades CS	Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.	Oncogene	2002	104
12376533	207	Beffert U	Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.	The Journal of biological chemistry	2002	84
12384559	207	Scotton CJ	Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.	Cancer research	2002	115
12727836	207	Grille SJ	The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.	Cancer research	2003	152
12897778	207	Matsunaga T	Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.	Nature medicine	2003	133
15723049	207	Ohanna M	Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.	Nature cell biology	2005	101
16023083	207	Shishodia S	Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.	Biochemical pharmacology	2005	78
16186396	207	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	91
16428510	207	Qian DZ	Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.	Clinical cancer research 	2006	71
16942488	207	Jia G	Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells.	Immunology and cell biology	2006	83
17043657	207	Baril P	Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.	Oncogene	2007	77
17563753	207	Julien S	Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition.	Oncogene	2007	132
17627510	207	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	64
18240972	207	Léger B	Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation.	Rejuvenation research	2008	59
19265662	207	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	219
19344728	207	Lecour S	Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?	Journal of molecular and cellular cardiology	2009	56
19483113	207	El Kebir D	15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.	American journal of respiratory and critical care medicine	2009	60
19597469	207	Dai J	Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.	Oncogene	2009	52
19762915	207	Yin W	Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways.	The Journal of biological chemistry	2009	49
19825827	207	Iliopoulos D	MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.	Science signaling	2009	87
20051626	207	Ginestier C	CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.	The Journal of clinical investigation	2010	205
20683952	207	Wang XQ	Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.	Hepatology	2010	54
20840586	207	Barash U	Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.	The FEBS journal	2010	66
21430222	207	Brown GT	Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles.	Journal of immunology	2011	41
22355189	207	Sun Y	Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection.	Science signaling	2012	47
22898879	207	Wu K	Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.	Hepatology	2012	43
23255107	207	Würth R	Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.	Cell cycle	2013	52
24096870	207	Liu PP	Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.	Cell death and differentiation	2014	38
24998913	207	Lee JV	Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.	Cell metabolism	2014	64
25288745	207	Oosting M	Human TLR10 is an anti-inflammatory pattern-recognition receptor.	Proceedings of the National Academy of Sciences of the United States of America	2014	30
25623055	207	Shu YJ	SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.	Molecular cancer	2015	22
15146422	214	Alsalameh S	Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage.	Arthritis and rheumatism	2004	89
17143262	214	Klein WM	Increased expression of stem cell markers in malignant melanoma.	Modern pathology 	2007	83
17348807	214	Varma MJ	Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells.	Stem cells and development	2007	58
17654479	214	Zannettino AC	Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo.	Journal of cellular physiology	2008	147
19626493	214	Horst D	Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.	Cancer investigation	2009	55
20528146	214	Halfon S	Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.	Stem cells and development	2011	83
21292246	214	Buckner CM	Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.	Cellular immunology	2011	45
24710410	214	Song Q	miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.	Cancer research	2014	26
12456604	268	van Rooij IA	Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.	Human reproduction	2002	127
14742691	268	Weenen C	Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.	Molecular human reproduction	2004	156
15820810	268	van Rooij IA	Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.	Fertility and sterility	2005	96
16804046	268	Hehenkamp WJ	Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.	The Journal of clinical endocrinology and metabolism	2006	72
16923748	268	La Marca A	Serum anti-Mullerian hormone throughout the human menstrual cycle.	Human reproduction	2006	74
18593767	268	Sowers MR	Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.	The Journal of clinical endocrinology and metabolism	2008	68
20522327	268	Hansen KR	Correlation of ovarian reserve tests with histologically determined primordial follicle number.	Fertility and sterility	2011	73
22137491	268	Gracia CR	Impact of cancer therapies on ovarian reserve.	Fertility and sterility	2012	31
22378815	268	Freeman EW	Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.	The Journal of clinical endocrinology and metabolism	2012	52
2469768	355	Yonehara S	A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.	The Journal of experimental medicine	1989	207
8946836	355	Strand S	Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?	Nature medicine	1996	129
9087414	355	Thome M	Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.	Nature	1997	280
10358758	355	Lenardo M	Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.	Annual review of immunology	1999	192
10601363	355	Kennedy NJ	Caspase activation is required for T cell proliferation.	The Journal of experimental medicine	1999	103
10779432	355	Fagnoni FF	Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging.	Blood	2000	91
15367603	355	Sanchez A	Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.	Journal of virology	2004	85
15607806	355	Smyth MJ	Activation of NK cell cytotoxicity.	Molecular immunology	2005	84
19155494	355	Strauss L	Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.	Journal of immunology	2009	50
19835841	355	Fuchs D	Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.	Biochemical and biophysical research communications	2009	49
7528780	356	Alderson MR	Fas ligand mediates activation-induced cell death in human T lymphocytes.	The Journal of experimental medicine	1995	167
8657285	356	Cuvillier O	Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate.	Nature	1996	267
9064324	356	O'Connell J	The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.	The Journal of experimental medicine	1996	132
9180075	356	Stenger S	Differential effects of cytolytic T cell subsets on intracellular infection.	Science	1997	114
10202932	356	Baize S	Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.	Nature medicine	1999	160
10690403	356	Nagata S	Fas ligand-induced apoptosis.	Annual review of genetics	1999	137
12637505	356	Mansouri A	Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.	The Journal of biological chemistry	2003	83
12709468	356	Imai Y	Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.	JAMA	2003	104
15655551	356	Taylor DD	Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects.	British journal of cancer	2005	87
15709166	356	Kim JW	Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.	Clinical cancer research 	2005	92
16424182	356	Taylor DD	Pregnancy-associated exosomes and their modulation of T cell signaling.	Journal of immunology	2006	85
19239902	356	Strasser A	The many roles of FAS receptor signaling in the immune system.	Immunity	2009	225
22723941	356	Sareen D	Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy.	PloS one	2012	47
22904309	356	Lugini L	Immune surveillance properties of human NK cell-derived exosomes.	Journal of immunology	2012	47
23177026	356	Wang P	The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL.	Molecular oncology	2013	32
24184557	356	Stenqvist AC	Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus.	Journal of immunology	2013	30
7812975	682	Biswas C	The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily.	Cancer research	1995	123
15781323	682	Gabison EE	EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.	Biochimie	2005	72
15833850	682	Tang Y	Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.	Cancer research	2005	89
16721788	682	Riethdorf S	High incidence of EMMPRIN expression in human tumors.	International journal of cancer	2006	60
17460779	682	Millimaggi D	Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.	Neoplasia	2007	56
24710016	682	Yoshioka Y	Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen.	Nature communications	2014	42
24880614	682	Bernard SC	Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization.	Nature medicine	2014	21
25268615	682	Xiong L	The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.	International journal of molecular sciences	2014	23
26990994	682	Albayrak C	Digital Quantification of Proteins and mRNA in Single Mammalian Cells.	Molecular cell	2016	14
18200009	684	Neil SJ	Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.	Nature	2008	726
19179289	684	Kaletsky RL	Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.	Proceedings of the National Academy of Sciences of the United States of America	2009	175
19214216	684	McNatt MW	Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.	PLoS pathogens	2009	170
19359243	684	Masuyama N	HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin.	The Journal of biological chemistry	2009	77
19461879	684	Gupta RK	Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.	PLoS pathogens	2009	117
19501037	684	Zhang F	Nef proteins from simian immunodeficiency viruses are tetherin antagonists.	Cell host and microbe	2009	193
19515779	684	Douglas JL	Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.	Journal of virology	2009	188
19740980	684	Le Tortorec A	Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.	Journal of virology	2009	149
19864625	684	Gupta RK	Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.	Proceedings of the National Academy of Sciences of the United States of America	2009	94
20078884	684	Schindler M	Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.	Retrovirology	2010	40
20167081	684	Yang SJ	Anti-tetherin activities in Vpu-expressing primate lentiviruses.	Retrovirology	2010	51
20193017	684	Swiecki M	Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.	Immunological reviews	2010	118
20221443	684	Fitzpatrick K	Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.	PLoS pathogens	2010	76
20419159	684	Pardieu C	The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.	PLoS pathogens	2010	81
20444895	684	Lopez LA	Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.	Journal of virology	2010	56
20686043	684	Radoshitzky SR	Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.	Journal of virology	2010	60
20688520	684	Evans DT	BST-2/tetherin: a new component of the innate immune response to enveloped viruses.	Trends in microbiology	2010	77
20880831	684	Schubert HL	Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations.	Proceedings of the National Academy of Sciences of the United States of America	2010	47
20926557	684	Vigan R	Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.	Journal of virology	2010	67
20940320	684	Yang H	Structural insight into the mechanisms of enveloped virus tethering by tetherin.	Proceedings of the National Academy of Sciences of the United States of America	2010	55
21068238	684	Kobayashi T	Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility.	Journal of virology	2011	50
21238946	684	Serra-Moreno R	Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV.	Cell host and microbe	2011	49
21610122	684	Schmidt S	HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction.	mBio	2011	42
21808013	684	Erikson E	In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans.	Proceedings of the National Academy of Sciences of the United States of America	2011	38
22315404	684	Pillai SK	Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
23028328	684	Cocka LJ	Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities.	PLoS pathogens	2012	64
23043100	684	Harris RS	The restriction factors of human immunodeficiency virus.	The Journal of biological chemistry	2012	100
23159053	684	Galão RP	Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses.	Cell host and microbe	2012	99
23221546	684	Tokarev A	Stimulation of NF-κB activity by the HIV restriction factor BST2.	Journal of virology	2013	68
24498878	684	Pham TN	HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.	Retrovirology	2014	43
1465456	960	Screaton GR	Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.	Proceedings of the National Academy of Sciences of the United States of America	1992	176
9445046	960	Summerford C	Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.	Journal of virology	1998	342
11325633	960	Puré E	A crucial role for CD44 in inflammation.	Trends in molecular medicine	2001	87
11381077	960	Kajita M	Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.	The Journal of cell biology	2001	149
12484499	960	Naor D	CD44 in cancer.	Critical reviews in clinical laboratory sciences	2002	119
12819017	960	de la Motte CA	Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function.	The American journal of pathology	2003	92
15070674	960	Avigdor A	CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.	Blood	2004	124
17638891	960	Patrawala L	Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.	Cancer research	2007	117
18193058	960	Sackstein R	Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.	Nature medicine	2008	138
18391223	960	Horwitz KB	Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.	Proceedings of the National Academy of Sciences of the United States of America	2008	58
18547053	960	Platt VM	Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.	Molecular pharmaceutics	2008	50
18980968	960	Du L	CD44 is of functional importance for colorectal cancer stem cells.	Clinical cancer research 	2008	146
19598259	960	Hong SP	CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.	International journal of cancer	2009	72
21098716	960	Krishnamurthy S	Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.	Cancer research	2010	68
21322081	960	Joshua B	Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness.	Head and neck	2012	38
21970856	960	Louderbough JM	Understanding the dual nature of CD44 in breast cancer progression.	Molecular cancer research 	2011	55
22637644	960	Rutnam ZJ	The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions.	Journal of cell science	2012	33
22654106	960	Qian H	Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein.	The Journal of biological chemistry	2012	36
23118219	960	Yang C	The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering.	The Journal of biological chemistry	2012	38
24036854	960	Shah V	Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.	Clinical cancer research 	2013	30
24145152	960	Christianson HC	Heparan sulfate proteoglycan as a cell-surface endocytosis receptor.	Matrix biology 	2014	38
24397969	960	Li L	Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.	Gastroenterology	2014	27
24618343	960	Lau WM	CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.	Cancer research	2014	27
25081533	960	Bourguignon LY	Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.	Advances in cancer research	2014	21
2007622	999	Frixen UH	E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.	The Journal of cell biology	1991	305
7585573	999	Graff JR	E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.	Cancer research	1995	160
8033105	999	Becker KF	E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.	Cancer research	1994	139
8199193	999	Birchmeier W	Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.	Biochimica et biophysica acta	1994	208
8557030	999	Berx G	E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.	The EMBO journal	1995	152
11597316	999	Berx G	The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.	Breast cancer research 	2001	92
14580257	999	Kowalski PJ	E-cadherin expression in primary carcinomas of the breast and its distant metastases.	Breast cancer research 	2003	102
16495925	999	Lombaerts M	E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.	British journal of cancer	2006	104
17545690	999	Kaurah P	Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.	JAMA	2007	66
18062917	999	Vesuna F	Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer.	Biochemical and biophysical research communications	2008	82
18398687	999	Hudson LG	Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.	Clinical and experimental metastasis	2008	65
18801366	999	Lim SO	Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.	Gastroenterology	2008	73
20406903	999	Xu Y	Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules.	Proceedings of the National Academy of Sciences of the United States of America	2010	114
20525219	999	Nagaoka M	Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum.	BMC developmental biology	2010	47
20591882	999	Fitzgerald RC	Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.	Journal of medical genetics	2010	71
21730131	999	Kim NG	E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.	Proceedings of the National Academy of Sciences of the United States of America	2011	138
22615930	999	Sun Y	Mechanics regulates fate decisions of human embryonic stem cells.	PloS one	2012	31
22647941	999	Li L	Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells.	Cell adhesion and migration	2012	34
23341533	999	Corso G	Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.	Journal of clinical oncology 	2013	28
23530113	999	Chu K	The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.	Oncotarget	2013	27
24442140	999	van Roy F	Beyond E-cadherin: roles of other cadherin superfamily members in cancer.	Nature reviews. Cancer	2014	52
24463987	999	Rodin S	Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment.	Nature communications	2014	47
25979631	999	van der Post RS	Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.	Journal of medical genetics	2015	26
8598933	1000	Nagar B	Structural basis of calcium-induced E-cadherin rigidification and dimerization.	Nature	1996	148
10545506	1000	Nieman MT	N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.	The Journal of cell biology	1999	175
10910081	1000	Tomita K	Cadherin switching in human prostate cancer progression.	Cancer research	2000	105
12062341	1000	Kostin S	Structural correlate of atrial fibrillation in human patients.	Cardiovascular research	2002	88
12414534	1000	Rosivatz E	Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.	The American journal of pathology	2002	133
12547715	1000	Hirakawa S	Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.	The American journal of pathology	2003	110
15579650	1000	Wang HS	Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.	Stem cells	2004	235
16405513	1000	Bentahir M	Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.	Journal of neurochemistry	2006	116
16618740	1000	Liu ZJ	Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.	Cancer research	2006	82
17311474	1000	Phan QT	Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells.	PLoS biology	2007	153
18056176	1000	Gravdal K	A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.	Clinical cancer research 	2007	115
18056451	1000	Eastham AM	Epithelial-mesenchymal transition events during human embryonic stem cell differentiation.	Cancer research	2007	75
18362184	1000	Shintani Y	Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1.	The Journal of cell biology	2008	64
18381457	1000	Graham TR	Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.	Cancer research	2008	119
19279339	1000	Asimaki A	A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.	The New England journal of medicine	2009	93
20082286	1000	Gao L	Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin.	Stem cells	2010	90
20368523	1000	Campagnolo P	Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential.	Circulation	2010	67
20808935	1000	Klopp AH	Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.	PloS one	2010	50
21125666	1000	Castilla MÁ	Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.	The Journal of pathology	2011	53
22844540	1000	Balasubramanian P	Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.	PloS one	2012	32
22912385	1000	Zhang J	Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.	Circulation research	2012	122
23197756	1000	Chen YS	Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.	Stem cells translational medicine	2012	38
23299311	1000	Zhang B	Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.	Blood	2013	59
23469181	1000	Wang P	Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.	PloS one	2013	32
23947765	1000	Gomez-Casal R	Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes.	Molecular cancer	2013	41
24201814	1000	Huang RY	An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).	Cell death and disease	2013	55
24325753	1000	Bocca C	Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.	Expert opinion on therapeutic targets	2014	25
25301732	1000	Wang D	Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.	Oncotarget	2014	35
25600338	1000	Wang H	The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.	Cancer cell	2015	37
25863539	1000	Wu Y	The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.	Oncotarget	2015	30
25945841	1000	Huang N	MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.	Oncotarget	2015	22
26069251	1000	Mudduluru G	A Systematic Approach to Defining the microRNA Landscape in Metastasis.	Cancer research	2015	15
26487301	1000	Yue B	LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.	Journal of gastroenterology and hepatology	2016	12
26668317	1000	Noy PJ	TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.	The Journal of biological chemistry	2016	10
9151786	1003	Zhou Y	Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?	The Journal of clinical investigation	1997	162
9625748	1003	Esser S	Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.	Journal of cell science	1998	157
10648408	1003	Peichev M	Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.	Blood	2000	409
11157668	1003	Gill M	Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.	Circulation research	2001	132
11401930	1003	Shintani S	Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.	Circulation	2001	156
11416160	1003	Hendrix MJ	Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.	Proceedings of the National Academy of Sciences of the United States of America	2001	97
11490021	1003	Shaw SK	Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium.	Journal of immunology	2001	88
11827993	1003	Reyes M	Origin of endothelial progenitors in human postnatal bone marrow.	The Journal of clinical investigation	2002	179
15345218	1003	Wang L	Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.	Immunity	2004	107
15533859	1003	Wojakowski W	Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.	Circulation	2004	73
16115630	1003	Kooistra MR	Epac1 regulates integrity of endothelial cell junctions through VE-cadherin.	FEBS letters	2005	108
16141364	1003	Weksler BB	Blood-brain barrier-specific properties of a human adult brain endothelial cell line.	FASEB journal 	2005	269
17060906	1003	Gavard J	VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.	Nature cell biology	2006	265
17767154	1003	Zheng B	Prospective identification of myogenic endothelial cells in human skeletal muscle.	Nature biotechnology	2007	107
18195090	1003	Birdsey GM	Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.	Blood	2008	69
18258663	1003	Förster C	Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.	The Journal of physiology	2008	59
18420943	1003	Schulz B	ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.	Circulation research	2008	58
18776942	1003	Murakami M	The FGF system has a key role in regulating vascular integrity.	The Journal of clinical investigation	2008	77
19658191	1003	Alvero AB	Stem-like ovarian cancer cells can serve as tumor vascular progenitors.	Stem cells	2009	56
19875721	1003	Nourse MB	VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.	Arteriosclerosis, thrombosis, and vascular biology	2010	43
20332120	1003	Lampugnani MG	CCM1 regulates vascular-lumen organization by inducing endothelial polarity.	Journal of cell science	2010	70
20457567	1003	Berx G	Involvement of members of the cadherin superfamily in cancer.	Cold Spring Harbor perspectives in biology	2009	142
21102433	1003	Wang R	Glioblastoma stem-like cells give rise to tumour endothelium.	Nature	2010	312
21123455	1003	Lo CW	IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.	Cancer research	2011	39
21630268	1003	Taverna S	Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.	International journal of cancer	2012	40
21876760	1003	Uosaki H	Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.	PloS one	2011	77
22326223	1003	Tran KV	The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells.	Cell metabolism	2012	81
22765916	1003	Redies C	Cadherins and neuropsychiatric disorders.	Brain research	2012	57
22981233	1003	Choi KD	Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures.	Cell reports	2012	48
23169780	1003	Rafii S	Human ESC-derived hemogenic endothelial cells undergo distinct waves of endothelial to hematopoietic transition.	Blood	2013	28
23520160	1003	Li J	Conversion of human fibroblasts to functional endothelial cells by defined factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	37
24589413	1003	Du J	Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.	Gynecologic oncology	2014	31
24992685	1003	Rochfort KD	Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.	PloS one	2014	24
26360820	1003	Mendoza FA	Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.	Arthritis and rheumatology	2016	10
16397211	1012	Fiegl H	Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.	Cancer research	2006	64
18316681	1012	Uhl GR	Genome-wide association for methamphetamine dependence: convergent results from 2 samples.	Archives of general psychiatry	2008	55
18337602	1012	Brock MV	DNA methylation markers and early recurrence in stage I lung cancer.	The New England journal of medicine	2008	147
18349282	1012	Feng Q	DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.	Cancer epidemiology, biomarkers and prevention 	2008	58
19581569	1012	Treutlein J	Genome-wide association study of alcohol dependence.	Archives of general psychiatry	2009	132
21658581	1012	Sanders SJ	Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.	Neuron	2011	391
21710692	1012	Moelans CB	Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.	The Journal of pathology	2011	39
22105624	1012	Franke B	The genetics of attention deficit/hyperactivity disorder in adults, a review.	Molecular psychiatry	2012	47
12035031	1048	Choti MA	Trends in long-term survival following liver resection for hepatic colorectal metastases.	Annals of surgery	2002	214
15520206	1048	Garnett CT	Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes.	Cancer research	2004	110
18483372	1048	Gulley JL	Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma.	Clinical cancer research 	2008	57
21112772	1048	Liu R	A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.	European journal of cancer	2011	129
21157437	1048	Parkhurst MR	T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.	Molecular therapy 	2011	164
22153832	1048	Grunnet M	Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.	Lung cancer	2012	47
12588754	1071	Barter PJ	Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2003	107
14559957	1071	Barzilai N	Unique lipoprotein phenotype and genotype associated with exceptional longevity.	JAMA	2003	157
17387129	1071	Nissen SE	Effect of torcetrapib on the progression of coronary atherosclerosis.	The New England journal of medicine	2007	149
17984165	1071	Barter PJ	Effects of torcetrapib in patients at high risk for coronary events.	The New England journal of medicine	2007	476
18536749	1071	Forrest MJ	Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.	British journal of pharmacology	2008	57
18560005	1071	Thompson A	Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.	JAMA	2008	117
19436720	1071	Xie L	Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.	PLoS computational biology	2009	79
19640950	1071	Qin Y	Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects.	The American journal of clinical nutrition	2009	48
20031564	1071	Ridker PM	Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.	Circulation. Cardiovascular genetics	2009	61
22089718	1071	Nicholls SJ	Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.	JAMA	2011	70
22234866	1071	Soerensen M	Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity.	Age	2013	25
22344176	1071	Zhang L	Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein.	Nature chemical biology	2012	36
22345126	1071	Lüscher TF	Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.	European heart journal	2012	34
23126252	1071	Schwartz GG	Effects of dalcetrapib in patients with a recent acute coronary syndrome.	The New England journal of medicine	2012	274
25038074	1071	Keene D	Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.	BMJ	2014	38
25629512	1071	Cheng CY	New loci and coding variants confer risk for age-related macular degeneration in East Asians.	Nature communications	2015	18
10202129	1084	Hammarström S	The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.	Seminars in cancer biology	1999	215
11274010	1084	Duffy MJ	Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?	Clinical chemistry	2001	94
12685552	1084	Terada T	Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth.	Pathology international	2002	96
15131794	1084	Brugge WR	Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.	Gastroenterology	2004	170
15205348	1084	Chakraborty M	External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.	Cancer research	2004	108
15613691	1084	Marshall JL	Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas.	Journal of clinical oncology 	2005	83
17060676	1084	Locker GY	ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.	Journal of clinical oncology 	2006	270
18362931	1084	Dai S	Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer.	Molecular therapy 	2008	93
18519811	1084	Morse MA	Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.	Blood	2008	101
18665430	1084	Kaushal S	Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.	Journal of gastrointestinal surgery 	2008	62
18818422	1084	Abd Hamid UM	A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.	Glycobiology	2008	59
19152896	1084	Khalid A	Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.	Gastrointestinal endoscopy	2009	78
20103634	1084	Galanis E	Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.	Cancer research	2010	98
21189474	1084	Rittig SM	Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.	Molecular therapy 	2011	36
21422427	1084	Iinuma H	Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.	Journal of clinical oncology 	2011	78
21775920	1084	Cizginer S	Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts.	Pancreas	2011	42
23315099	1084	Haas M	Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.	Journal of cancer research and clinical oncology	2013	29
23331006	1084	Poruk KE	The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.	Current molecular medicine	2013	26
23572188	1084	Shimada H	Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.	Gastric cancer 	2014	32
23657083	1084	Morse MA	A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.	Annals of surgery	2013	30
23672279	1084	He CZ	Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.	BMC gastroenterology	2013	29
24249594	1084	Metildi CA	Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.	Journal of surgical oncology	2014	42
24373959	1084	Hiroshima Y	Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.	The Journal of surgical research	2014	33
24430319	1084	Primrose JN	Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.	JAMA	2014	39
24494971	1084	Hiroshima Y	Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.	Journal of laparoendoscopic and advanced surgical techniques. Part A	2014	37
25273947	1084	Liu L	A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer.	International journal of cancer	2015	19
15753362	1116	Nigro JM	Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.	Cancer research	2005	91
17538175	1116	Pelloski CE	Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.	Journal of clinical oncology 	2007	78
18003958	1116	Chupp GL	A chitinase-like protein in the lung and circulation of patients with severe asthma.	The New England journal of medicine	2007	143
18403759	1116	Ober C	Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.	The New England journal of medicine	2008	151
18802121	1116	Létuvé S	YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.	Journal of immunology	2008	64
19767768	1116	Shao R	YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.	Oncogene	2009	71
21054166	1116	Lee CG	Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.	Annual review of physiology	2011	153
21357475	1116	Faibish M	A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers.	Molecular cancer therapeutics	2011	41
21385870	1116	Francescone RA	Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.	The Journal of biological chemistry	2011	55
21393864	1116	Zeng M	Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections.	The Journal of clinical investigation	2011	101
16113678	1191	Zhang H	Clusterin inhibits apoptosis by interacting with activated Bax.	Nature cell biology	2005	98
16179938	1191	Shannan B	Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.	Cell death and differentiation	2006	60
17077814	1191	Bell RD	Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.	Journal of cerebral blood flow and metabolism 	2007	139
20554627	1191	Carrasquillo MM	Replication of CLU, CR1, and PICALM associations with alzheimer disease.	Archives of neurology	2010	71
20603455	1191	Thambisetty M	Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.	Archives of general psychiatry	2010	85
20697030	1191	Jun G	Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.	Archives of neurology	2010	120
21059989	1191	Lee JH	Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals.	Archives of neurology	2011	54
21467285	1191	Schrijvers EM	Plasma clusterin and the risk of Alzheimer disease.	JAMA	2011	49
21543606	1191	Braskie MN	Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults.	The Journal of neuroscience 	2011	65
21824521	1191	Thambisetty M	Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.	NeuroImage	2012	31
22179788	1191	Narayan P	The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide.	Nature structural and molecular biology	2011	62
10537110	1236	Sallusto F	Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.	Nature	1999	1345
11592079	1236	Krug A	Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.	European journal of immunology	2001	142
11602640	1236	Bouchon A	A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.	The Journal of experimental medicine	2001	105
11745357	1236	Jarrossay D	Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.	European journal of immunology	2001	160
12414515	1236	Muller DN	Immunosuppressive treatment protects against angiotensin II-induced renal damage.	The American journal of pathology	2002	83
12829791	1236	Kivisäkk P	Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.	Proceedings of the National Academy of Sciences of the United States of America	2003	90
12975468	1236	Day CL	Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.	The Journal of clinical investigation	2003	101
15342370	1236	Mailliard RB	alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.	Cancer research	2004	139
16034093	1236	Caron G	Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.	Journal of immunology	2005	119
16203865	1236	Mailliard RB	IL-18-induced CD83+CCR7+ NK helper cells.	The Journal of experimental medicine	2005	69
16547270	1236	Ebert LM	Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance.	Journal of immunology	2006	66
16917003	1236	Hoffmann P	Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.	Blood	2006	98
17182569	1236	Strauss L	Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.	Journal of immunology	2007	105
17371966	1236	Romero P	Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.	Journal of immunology	2007	96
18390722	1236	Seubert A	The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.	Journal of immunology	2008	64
18820174	1236	Chattopadhyay PK	The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.	Journal of leukocyte biology	2009	76
19933869	1236	Akondy RS	The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.	Journal of immunology	2009	100
21926977	1236	Gattinoni L	A human memory T cell subset with stem cell-like properties.	Nature medicine	2011	318
25470347	1236	Peferoen LA	Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.	Journal of neuropathology and experimental neurology	2015	20
16227410	1244	Safaei R	Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells.	Molecular cancer therapeutics	2005	90
16330681	1244	Wojnowski L	NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity.	Circulation	2005	70
20124171	1244	Kiyotani K	Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.	Journal of clinical oncology 	2010	45
21103974	1244	Keppler D	Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.	Handbook of experimental pharmacology	2011	51
26499806	1244	Chen Z	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.	Cancer letters	2016	26
7934491	1401	Elliott MJ	Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.	Lancet	1994	216
8250987	1401	Elliott MJ	Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.	Arthritis and rheumatism	1993	134
9751087	1401	Maini RN	Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.	Arthritis and rheumatism	1998	198
9870876	1401	Bresnihan B	Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.	Arthritis and rheumatism	1998	137
10231453	1401	Stenvinkel P	Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.	Kidney international	1999	158
10368284	1401	Thompson D	The physiological structure of human C-reactive protein and its complex with phosphocholine.	Structure	1999	107
10700656	1401	Lanquillon S	Cytokine production and treatment response in major depressive disorder.	Neuropsychopharmacology 	2000	125
10733371	1401	Ridker PM	C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.	The New England journal of medicine	2000	789
10999830	1401	Bastard JP	Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.	The Journal of clinical endocrinology and metabolism	2000	129
11056086	1401	Pasceri V	Direct proinflammatory effect of C-reactive protein on human endothelial cells.	Circulation	2000	195
11916939	1401	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	94
11986408	1401	Gorman JD	Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.	The New England journal of medicine	2002	80
12366601	1401	Blake GJ	Inflammatory bio-markers and cardiovascular risk prediction.	Journal of internal medicine	2002	90
12390945	1401	Hürlimann D	Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.	Circulation	2002	84
12515748	1401	Shlipak MG	Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.	Circulation	2003	125
12654604	1401	Vasan RS	Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.	Circulation	2003	103
12796126	1401	Chung ES	Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.	Circulation	2003	153
12847160	1401	Yaffe K	Inflammatory markers and cognition in well-functioning African-American and white elders.	Neurology	2003	159
12943870	1401	Cesari M	Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition Health ABC Study).	The American journal of cardiology	2003	80
12946885	1401	Penninx BW	Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.	Biological psychiatry	2003	108
14568895	1401	Cesari M	Inflammatory markers and onset of cardiovascular events: results from the Health ABC study.	Circulation	2003	180
15048997	1401	Kuhn E	Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards.	Proteomics	2004	85
15209648	1401	Penninx BW	Inflammatory markers and incident mobility limitation in the elderly.	Journal of the American Geriatrics Society	2004	83
15234425	1401	Chrysohoou C	Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.	Journal of the American College of Cardiology	2004	90
15280421	1401	Ehrenstein MR	Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.	The Journal of experimental medicine	2004	276
15308518	1401	Forslind K	Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).	Annals of the rheumatic diseases	2004	90
15447916	1401	Lopez-Garcia E	Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2004	141
15477419	1401	Latini R	Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.	Circulation	2004	80
15818697	1401	Smolen JS	Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.	Arthritis and rheumatism	2005	79
15855252	1401	Karelis AD	The metabolically healthy but obese individual presents a favorable inflammation profile.	The Journal of clinical endocrinology and metabolism	2005	115
15955978	1401	Seddon JM	Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.	Archives of ophthalmology	2005	90
16002815	1401	Fung TT	Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2005	118
16087797	1401	Tzoulaki I	C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.	Circulation	2005	79
16234304	1401	Ferrucci L	Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.	The Journal of clinical endocrinology and metabolism	2006	121
16267155	1401	Shlipak MG	Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.	Journal of the American Society of Nephrology 	2006	66
16284220	1401	Yende S	Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.	Thorax	2006	64
16412867	1401	Meyer TE	Long-term caloric restriction ameliorates the decline in diastolic function in humans.	Journal of the American College of Cardiology	2006	79
16505242	1401	Devaraj S	Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.	Diabetes	2006	84
16784934	1401	Ferrario CM	Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.	The American journal of cardiology	2006	95
17324119	1401	Savoia C	Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.	Clinical science	2007	72
17329698	1401	Tonetti MS	Treatment of periodontitis and endothelial function.	The New England journal of medicine	2007	166
17389308	1401	Jefferson AL	Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study.	Neurology	2007	64
17524614	1401	Frey DJ	The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults.	Brain, behavior, and immunity	2007	71
17536046	1401	Tan ZS	Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.	Neurology	2007	116
17634458	1401	Sandborn WJ	Certolizumab pegol for the treatment of Crohn's disease.	The New England journal of medicine	2007	129
17634459	1401	Schreiber S	Maintenance therapy with certolizumab pegol for Crohn's disease.	The New England journal of medicine	2007	121
17890755	1401	Chen H	Peripheral inflammatory biomarkers and risk of Parkinson's disease.	American journal of epidemiology	2008	64
17916108	1401	Langhorst J	Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.	The American journal of gastroenterology	2008	96
17997848	1401	Armah HB	Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children.	Malaria journal	2007	76
18022866	1401	Sipponen T	Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.	Inflammatory bowel diseases	2008	65
18172326	1401	Kim S	Circulating levels of inflammatory cytokines and risk of colorectal adenomas.	Cancer research	2008	71
18285417	1401	Ding C	Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.	The Journal of clinical endocrinology and metabolism	2008	54
18942885	1401	Kuller LH	Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.	PLoS medicine	2008	516
19011614	1401	Lu J	Structural recognition and functional activation of FcgammaR by innate pentraxins.	Nature	2008	67
19060001	1401	van der Heijde D	ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.	Annals of the rheumatic diseases	2009	50
19070949	1401	Rambod M	Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.	American journal of kidney diseases 	2009	53
19165157	1401	Beasley LE	Inflammation and race and gender differences in computerized tomography-measured adipose depots.	Obesity	2009	54
19196644	1401	Brinkley TE	Chronic inflammation is associated with low physical function in older adults across multiple comorbidities.	The journals of gerontology. Series A, Biological sciences and medical sciences	2009	69
19477372	1401	Zakynthinos E	Inflammatory biomarkers in coronary artery disease.	Journal of cardiology	2009	47
19565477	1401	Livshits G	Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study.	Arthritis and rheumatism	2009	52
19622801	1401	Schaap LA	Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength.	The journals of gerontology. Series A, Biological sciences and medical sciences	2009	89
19695853	1401	Balducci S	Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.	Nutrition, metabolism, and cardiovascular diseases 	2010	80
19712036	1401	Ross AC	Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.	Clinical infectious diseases 	2009	75
20016471	1401	Barreto DV	Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.	Kidney international	2010	51
20203163	1401	Matias PJ	Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.	Clinical journal of the American Society of Nephrology 	2010	43
20605303	1401	Shafi T	Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.	American journal of kidney diseases 	2010	42
20610634	1401	Thurnham DI	Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis.	The American journal of clinical nutrition	2010	82
20718771	1401	Kalinchenko SY	Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.	Clinical endocrinology	2010	65
21252259	1401	Sandler NG	Plasma levels of soluble CD14 independently predict mortality in HIV infection.	The Journal of infectious diseases	2011	346
21253011	1401	Boulware DR	Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.	PLoS medicine	2010	85
21560033	1401	Shozushima T	Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.	Journal of infection and chemotherapy 	2011	39
22237295	1401	Bind MA	Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort.	Epidemiology	2012	67
22345378	1401	Wood LG	The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma.	Chest	2012	46
22546988	1401	McComsey GA	Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.	AIDS	2012	34
22624038	1401	Agustí A	Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.	PloS one	2012	123
22809118	1401	Su L	Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.	BMC infectious diseases	2012	41
22889633	1401	Johnson GH	Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials.	Journal of the Academy of Nutrition and Dietetics	2012	31
22915618	1401	Hughes-Austin JM	Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA).	Annals of the rheumatic diseases	2013	26
23089630	1401	Lamers F	Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.	Molecular psychiatry	2013	65
23612048	1401	Vogelzangs N	Anxiety disorders and inflammation in a large adult cohort.	Translational psychiatry	2013	49
23818109	1401	Haroon N	The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.	Arthritis and rheumatism	2013	52
23979951	1401	Phillips CM	Does inflammation determine metabolic health status in obese and nonobese adults?	The Journal of clinical endocrinology and metabolism	2013	36
24481424	1401	Klein R	Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.	JAMA ophthalmology	2014	31
24623718	1401	Genovese MC	A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors.	Arthritis and rheumatology	2014	29
24864079	1401	Ridker PM	Anti-inflammatory therapies for cardiovascular disease.	European heart journal	2014	40
25190134	1401	Behnes M	Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.	Critical care	2014	28
25640603	1401	Wright KP Jr	Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance.	Brain, behavior, and immunity	2015	15
25710246	1401	Hajat A	Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA).	Epidemiology	2015	21
25724455	1401	Vande Casteele N	Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.	Gastroenterology	2015	29
25732419	1401	Menees SB	A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.	The American journal of gastroenterology	2015	23
26065825	1401	Haapakoski R	Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.	Brain, behavior, and immunity	2015	28
26530445	1401	Ishizuka M	Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.	Annals of surgical oncology	2016	13
27338587	1401	Giloteaux L	Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.	Microbiome	2016	14
7535770	1432	Raingeaud J	Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine.	The Journal of biological chemistry	1995	395
7997261	1432	Lee JC	A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.	Nature	1994	535
9452444	1432	Vanden Berghe W	p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.	The Journal of biological chemistry	1998	120
10604986	1432	Kol A	Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells.	Journal of immunology	2000	102
10623843	1432	Hartmann G	Mechanism and function of a newly identified CpG DNA motif in human primary B cells.	Journal of immunology	2000	93
10943842	1432	Tamura K	Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis.	Cell	2000	99
12065755	1432	Laping NJ	Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.	Molecular pharmacology	2002	138
14699082	1432	Doyle SE	Toll-like receptors induce a phagocytic gene program through p38.	The Journal of experimental medicine	2004	95
15728187	1432	Zhu CB	p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.	The Journal of biological chemistry	2005	68
16402404	1432	Sadeghi K	Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.	European journal of immunology	2006	100
17170118	1432	Sun L	Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.	The Journal of biological chemistry	2007	69
17392283	1432	Medvedev AE	Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.	The Journal of biological chemistry	2007	61
18420487	1432	Busik JV	Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators.	Diabetes	2008	75
18629684	1432	Nieto-Vazquez I	Insulin resistance associated to obesity: the link TNF-alpha.	Archives of physiology and biochemistry	2008	72
19124752	1432	Hui KP	Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK.	Journal of immunology	2009	56
19482216	1432	Barnes PJ	Glucocorticoid resistance in inflammatory diseases.	Lancet	2009	180
20802523	1432	Wendt MK	Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.	Oncogene	2010	75
21490934	1432	Crişan TO	Inflammasome-independent modulation of cytokine response by autophagy in human cells.	PloS one	2011	40
24362529	1432	Xiang T	Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.	Oncogene	2015	21
25666404	1432	Bäck M	Anti-inflammatory therapies for atherosclerosis.	Nature reviews. Cardiology	2015	24
26601950	1432	Purushothaman A	Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions.	The Journal of biological chemistry	2016	17
3258626	1435	Gendelman HE	Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.	The Journal of experimental medicine	1988	307
8760823	1435	Caux C	CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.	The Journal of experimental medicine	1996	125
9618145	1435	Majumdar MK	Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.	Journal of cellular physiology	1998	120
9845545	1435	Menetrier-Caux C	Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.	Blood	1998	102
11509180	1435	Liu R	Regulation of CSF1 promoter by the SWI/SNF-like BAF complex.	Cell	2001	104
12639988	1435	Ritchlin CT	Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.	The Journal of clinical investigation	2003	106
15062647	1435	Barreda DR	Regulation of myeloid development and function by colony stimulating factors.	Developmental and comparative immunology	2004	74
17082649	1435	Martinez FO	Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.	Journal of immunology	2006	524
17374712	1435	Harman-Boehm I	Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity.	The Journal of clinical endocrinology and metabolism	2007	106
18332234	1435	Shao DD	Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation.	Journal of leukocyte biology	2008	85
18553315	1435	Komohara Y	Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.	The Journal of pathology	2008	120
19188147	1435	Beck AH	The macrophage colony-stimulating factor 1 response signature in breast carcinoma.	Clinical cancer research 	2009	58
19299742	1435	Leidi M	M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.	Journal of immunology	2009	73
19432671	1435	Kawamura K	Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.	Pathology international	2009	55
19934330	1435	Patsialou A	Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.	Cancer research	2009	94
20335529	1435	Gleissner CA	CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.	Journal of immunology	2010	47
20580464	1435	Sierra-Filardi E	Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.	Immunobiology	2010	50
21890660	1435	Svensson J	Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10.	Journal of immunology	2011	47
21911939	1435	Vogt G	In vitro differentiation of human macrophages with enhanced antimycobacterial activity.	The Journal of clinical investigation	2011	38
22186992	1435	Hume DA	Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.	Blood	2012	106
22547697	1435	Lacey DC	Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models.	Journal of immunology	2012	85
24521472	1435	Mia S	An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype.	Scandinavian journal of immunology	2014	23
25429076	1435	Pignatelli J	Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.	Science signaling	2014	23
26538619	1435	Stafford JH	Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.	Neuro-oncology	2016	15
1940799	1437	de Waal Malefyt R	Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.	The Journal of experimental medicine	1991	645
2181447	1437	Gilliland G	Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.	Proceedings of the National Academy of Sciences of the United States of America	1990	176
3488815	1437	Shaw G	A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.	Cell	1986	914
3923623	1437	Wong GG	Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.	Science	1985	191
7629501	1437	Sallusto F	Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.	The Journal of experimental medicine	1995	427
7814646	1437	Jung HC	A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.	The Journal of clinical investigation	1995	297
8006603	1437	Romani N	Proliferating dendritic cell progenitors in human blood.	The Journal of experimental medicine	1994	266
8145033	1437	Sallusto F	Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.	The Journal of experimental medicine	1994	905
8274730	1437	Tilg H	Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.	Blood	1994	127
8841451	1437	Bender A	Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.	Journal of immunological methods	1996	112
9712065	1437	Luft T	Type I IFNs enhance the terminal differentiation of dendritic cells.	Journal of immunology	1998	123
10389921	1437	Chen Z	Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.	Clinical cancer research 	1999	112
10679127	1437	Ziolkowska M	High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.	Journal of immunology	2000	141
10811870	1437	Santini SM	Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.	The Journal of experimental medicine	2000	112
10866317	1437	Mach N	Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.	Cancer research	2000	115
11238037	1437	Sugiyama S	Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.	The American journal of pathology	2001	100
12473579	1437	Giaccone G	A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.	Clinical cancer research 	2002	124
12829592	1437	Hayashi F	Toll-like receptors stimulate human neutrophil function.	Blood	2003	187
15289501	1437	Thomas AM	Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.	The Journal of experimental medicine	2004	104
15634923	1437	Schaefer TM	Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C).	Journal of immunology	2005	78
15661881	1437	Gorden KB	Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.	Journal of immunology	2005	147
15871677	1437	Hughes MS	Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.	Human gene therapy	2005	77
15917384	1437	Korzenik JR	Sargramostim for active Crohn's disease.	The New England journal of medicine	2005	67
16204061	1437	Queen MM	Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.	Cancer research	2005	73
16951685	1437	Rossi AG	Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.	Nature medicine	2006	138
17116643	1437	Parmiani G	Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients.	Annals of oncology 	2007	65
17121894	1437	Hu JC	A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.	Clinical cancer research 	2006	109
17133347	1437	Hau HH	Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.	Journal of cellular biochemistry	2007	56
17220794	1437	Ramasamy R	Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.	Transplantation	2007	89
17284714	1437	Hershman D	Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.	Journal of the National Cancer Institute	2007	70
17577033	1437	Filipazzi P	Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.	Journal of clinical oncology 	2007	230
17606721	1437	Small EJ	Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.	Clinical cancer research 	2007	63
17965776	1437	Thorne SH	Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.	The Journal of clinical investigation	2007	65
18202348	1437	Inoue Y	Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.	American journal of respiratory and critical care medicine	2008	50
18287062	1437	Hodi FS	Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2008	171
18316569	1437	Laheru D	Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation.	Clinical cancer research 	2008	95
18495536	1437	Park BH	Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.	The Lancet. Oncology	2008	135
18628758	1437	Liu TC	The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma.	Molecular therapy 	2008	62
18646045	1437	Higano CS	Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.	Cancer	2008	55
18692472	1437	Hansen G	The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.	Cell	2008	74
19147575	1437	Fong L	Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.	Cancer research	2009	83
19201905	1437	Motohashi S	A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.	Journal of immunology	2009	54
19228745	1437	Kirkwood JM	Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.	Clinical cancer research 	2009	48
19308771	1437	Berg M	Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.	Cytotherapy	2009	72
19590022	1437	Meisel C	Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.	American journal of respiratory and critical care medicine	2009	113
19609242	1437	Weide B	Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.	Journal of immunotherapy	2009	45
19636017	1437	McNeel DG	Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.	Journal of clinical oncology 	2009	74
19666104	1437	Enstrom AM	Differential monocyte responses to TLR ligands in children with autism spectrum disorders.	Brain, behavior, and immunity	2010	73
19726877	1437	Choi KD	Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors.	The Journal of clinical investigation	2009	55
19805669	1437	Emens LA	Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.	Journal of clinical oncology 	2009	69
19890632	1437	Gulley JL	Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.	Cancer immunology, immunotherapy 	2010	109
19903780	1437	Slingluff CL Jr	Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.	Clinical cancer research 	2009	62
19915919	1437	Kaufman HL	Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.	Annals of surgical oncology	2010	118
20030565	1437	Frugier T	In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury.	Journal of neurotrauma	2010	55
20083662	1437	Torres-Aguilar H	Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.	Journal of immunology	2010	55
20386463	1437	Correale P	Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.	Journal of immunotherapy	2010	60
20484030	1437	Cerullo V	Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients.	Cancer research	2010	69
20528232	1437	Kaufman HL	OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma.	Future oncology	2010	56
20664527	1437	Koski A	Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.	Molecular therapy 	2010	69
20833247	1437	Ashwood P	Altered T cell responses in children with autism.	Brain, behavior, and immunity	2011	60
20879881	1437	Yu AL	Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.	The New England journal of medicine	2010	283
21217520	1437	Lutz E	A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.	Annals of surgery	2011	94
21337337	1437	Zawada JF	Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines.	Biotechnology and bioengineering	2011	47
21628671	1437	Lai L	Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.	The Journal of infectious diseases	2011	58
21630267	1437	Pesonen S	Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.	International journal of cancer	2012	32
21734236	1437	Solito S	A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.	Blood	2011	77
21772252	1437	Hwang TH	A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma.	Molecular therapy 	2011	42
21926600	1437	Paine R 3rd	A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.	Critical care medicine	2012	35
21989902	1437	Mittendorf EA	Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.	Cancer	2012	34
22822024	1437	Leentjens J	Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.	American journal of respiratory and critical care medicine	2012	32
23088985	1437	Burke JM	A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer.	The Journal of urology	2012	38
23401569	1437	Broxmeyer HE	Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration.	The Journal of experimental medicine	2013	27
23493351	1437	Kanerva A	Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus.	Clinical cancer research 	2013	42
23509356	1437	Rosen LB	Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.	Journal of immunology	2013	40
23637915	1437	Matsushita T	Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.	PloS one	2013	26
23924790	1437	Le DT	Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.	Journal of immunotherapy	2013	92
24458546	1437	Helm O	Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.	International journal of cancer	2014	25
24534756	1437	Behrens F	MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.	Annals of the rheumatic diseases	2015	28
24643864	1437	Saijo T	Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.	mBio	2014	30
24691121	1437	Choi SS	Human astrocytes: secretome profiles of cytokines and chemokines.	PloS one	2014	31
24816404	1437	Wu P	γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.	Immunity	2014	60
24823638	1437	Su S	A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.	Cancer cell	2014	85
24907636	1437	Mittendorf EA	Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.	Annals of oncology 	2014	28
24954781	1437	Middleton G	Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.	The Lancet. Oncology	2014	45
25215458	1437	Singh VK	Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.	Cytokine	2015	20
25369488	1437	Hodi FS	Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.	JAMA	2014	51
25714011	1437	Hemminki O	Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy.	Oncotarget	2015	21
26014293	1437	Andtbacka RH	Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.	Journal of clinical oncology 	2015	197
26095785	1437	Golden EB	Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.	The Lancet. Oncology	2015	50
26104913	1437	Arnold KB	Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells.	Mucosal immunology	2016	23
26491076	1437	Li R	Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.	Science translational medicine	2015	28
26633290	1437	Wicks IP	Targeting GM-CSF in inflammatory diseases.	Nature reviews. Rheumatology	2016	16
26719429	1437	Kohlhapp FJ	Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy.	Clinical cancer research 	2016	11
26783184	1437	Scheibe K	IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.	Gut	2017	7
27374224	1437	Singhal S	Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.	Cancer cell	2016	13
11172139	1440	Bensinger WI	Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.	The New England journal of medicine	2001	99
12791654	1440	Maris MB	HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.	Blood	2003	79
12974876	1440	Treutiger CJ	High mobility group 1 B-box mediates activation of human endothelium.	Journal of internal medicine	2003	82
15016484	1440	Kang HJ	Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.	Lancet	2004	111
15824174	1440	Gorelik E	Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.	Cancer epidemiology, biomarkers and prevention 	2005	82
15890685	1440	Flomenberg N	The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.	Blood	2005	87
16046292	1440	Cancello R	Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss.	Diabetes	2005	222
16497969	1440	Rosenberg PS	The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.	Blood	2006	72
16507801	1440	Zohlnhöfer D	Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.	JAMA	2006	77
16531621	1440	Ripa RS	Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.	Circulation	2006	60
16682719	1440	Smith TJ	2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.	Journal of clinical oncology 	2006	254
16750358	1440	Aapro MS	EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.	European journal of cancer	2006	72
16883008	1440	Kang WJ	Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.	Journal of nuclear medicine 	2006	62
17330101	1440	Jiang X	Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.	Leukemia	2007	80
18832668	1440	von Vietinghoff S	Homeostatic regulation of blood neutrophil counts.	Journal of immunology	2008	64
19161986	1440	De Clercq E	The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).	Biochemical pharmacology	2009	55
19363221	1440	DiPersio JF	Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.	Blood	2009	104
19711453	1440	Kawamoto A	Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.	Stem cells	2009	49
19720922	1440	DiPersio JF	Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.	Journal of clinical oncology 	2009	97
20160717	1440	Saito Y	Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.	Nature biotechnology	2010	85
20599449	1440	Essers MA	Targeting leukemic stem cells by breaking their dormancy.	Molecular oncology	2010	46
21095116	1440	Aapro MS	2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.	European journal of cancer	2011	120
21636707	1440	Raychaudhuri B	Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.	Neuro-oncology	2011	85
21886173	1440	Rettig MP	Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.	Leukemia	2012	46
21907922	1440	Granot Z	Tumor entrained neutrophils inhibit seeding in the premetastatic lung.	Cancer cell	2011	105
22119930	1440	Garg V	Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.	Gastroenterology	2012	41
22828446	1440	Mougiakakos D	Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.	Leukemia	2013	27
22841419	1440	Elliott MJ	Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study.	Lancet	2012	55
23111057	1440	Fadini GP	Diabetes impairs stem cell and proangiogenic cell mobilization in humans.	Diabetes care	2013	30
23165479	1440	Di Bartolomeo P	Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.	Blood	2013	33
23963331	1440	Ringelstein EB	Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.	Stroke	2013	28
24621603	1440	Acosta SA	Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury.	PloS one	2014	29
25131807	1440	Bendall LJ	G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.	Cytokine and growth factor reviews	2014	32
25303306	1440	Fischer JA	Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.	Arthritis and rheumatology	2015	26
25500887	1440	Haller MJ	Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.	The Journal of clinical investigation	2015	18
7534620	1493	Linsley PS	Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.	Immunity	1994	143
11067871	1493	Jonuleit H	Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.	The Journal of experimental medicine	2000	253
12826605	1493	Phan GQ	Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.	Proceedings of the National Academy of Sciences of the United States of America	2003	320
15034022	1493	Munn DH	Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.	Journal of immunology	2004	109
15613700	1493	Sanderson K	Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma.	Journal of clinical oncology 	2005	85
15785759	1493	von Boehmer H	Mechanisms of suppression by suppressor T cells.	Nature immunology	2005	230
15914560	1493	Beyer M	Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.	Blood	2005	103
16301685	1493	Maker AV	Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.	Journal of immunology	2005	75
18512248	1493	Hölttä V	IL-23/IL-17 immunity as a hallmark of Crohn's disease.	Inflammatory bowel diseases	2008	52
18523152	1493	Kavanagh B	CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.	Blood	2008	59
19338264	1493	Oble DA	Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.	Cancer immunity	2009	53
20126406	1493	Prasanna SJ	Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.	PloS one	2010	71
20596022	1493	Petukhova L	Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.	Nature	2010	94
21074063	1493	Callahan MK	Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy.	Seminars in oncology	2010	59
21205883	1493	Steck AK	Genetics of type 1 diabetes.	Clinical chemistry	2011	40
22878899	1493	Santegoets SJ	T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment.	Cancer immunology, immunotherapy 	2013	29
23960017	1493	Han Y	Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.	Hepatology	2014	26
24357148	1493	Meyer C	Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab.	Cancer immunology, immunotherapy 	2014	54
24514956	1493	Jochems C	A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.	Cancer immunology, immunotherapy 	2014	23
24795351	1493	Anderson AC	Tim-3: an emerging target in the cancer immunotherapy landscape.	Cancer immunology research	2014	30
25824720	1493	Carosella ED	A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.	European urology	2015	24
25918390	1493	Romano E	Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2015	38
25993145	1493	Postow MA	Managing immune checkpoint-blocking antibody side effects.	American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting	2015	32
27192565	1493	Anderson AC	Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.	Immunity	2016	32
9708792	1499	Hirohashi S	Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.	The American journal of pathology	1998	161
9990071	1499	Mann B	Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.	Proceedings of the National Academy of Sciences of the United States of America	1999	180
10074433	1499	Hart M	The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.	Current biology 	1999	175
10630639	1499	Miller JR	Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways.	Oncogene	1999	124
11381089	1499	Gottardi CJ	E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.	The Journal of cell biology	2001	150
11533658	1499	Ryo A	Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.	Nature cell biology	2001	131
12398896	1499	Deng J	beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer.	Cancer cell	2002	91
12841864	1499	Hirohashi S	Cell adhesion system and human cancer morphogenesis.	Cancer science	2003	82
14623871	1499	Conacci-Sorrell M	Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.	The Journal of cell biology	2003	120
14706341	1499	Lu Z	Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.	Cancer cell	2003	169
16023783	1499	Verras M	Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.	Cancer letters	2006	72
16146765	1499	Larue L	The WNT/Beta-catenin pathway in melanoma.	Frontiers in bioscience 	2006	67
16288032	1499	Huang L	MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.	Cancer research	2005	99
16357527	1499	Kim KA	R-Spondin proteins: a novel link to beta-catenin activation.	Cell cycle	2006	72
16449977	1499	Patrawala L	Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.	Oncogene	2006	284
16857785	1499	Yang AD	Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.	Clinical cancer research 	2006	132
17413031	1499	Ross AJ	Transcriptional profiling of mucociliary differentiation in human airway epithelial cells.	American journal of respiratory cell and molecular biology	2007	80
17909916	1499	Shah AN	Development and characterization of gemcitabine-resistant pancreatic tumor cells.	Annals of surgical oncology	2007	149
18006828	1499	Yamashita T	Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.	Cancer research	2007	113
18339862	1499	Li H	PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.	Cancer research	2008	76
18381440	1499	Sawada K	Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.	Cancer research	2008	104
18555664	1499	Jin T	Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.	Cellular signalling	2008	72
18667462	1499	Sumi T	Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling.	Development	2008	94
18697834	1499	Otto A	Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration.	Journal of cell science	2008	66
19047049	1499	Bourguignon LY	Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.	The Journal of biological chemistry	2009	47
19160483	1499	Simpson KJ	Identification of genes that regulate epithelial cell migration using an siRNA screening approach.	Nature cell biology	2008	158
19270709	1499	Hong HS	A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells.	Nature medicine	2009	50
19279717	1499	Komiya Y	Wnt signal transduction pathways.	Organogenesis	2008	140
19666525	1499	Chan KS	Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	149
19703993	1499	Saydam O	Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.	Molecular and cellular biology	2009	83
19915524	1499	Liu LK	Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome.	Modern pathology 	2010	47
20227366	1499	Tauriello DV	Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.	Molecular cell	2010	46
20227497	1499	Haussler MR	The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging.	The Journal of steroid biochemistry and molecular biology	2010	47
20610629	1499	Gu Y	GlcNAcylation plays an essential role in breast cancer metastasis.	Cancer research	2010	44
21880956	1499	Zemans RL	Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
21885974	1499	Lam AP	β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target.	Current opinion in rheumatology	2011	43
22007144	1499	Tian X	E-cadherin/β-catenin complex and the epithelial barrier.	Journal of biomedicine and biotechnology	2011	56
22095947	1499	He W	Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.	Journal of the American Society of Nephrology 	2012	40
22580612	1499	Kufe DW	MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.	Oncogene	2013	82
22704062	1499	Chaw SY	Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.	Oral oncology	2012	39
23333633	1499	Chiang CH	Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.	Biochimica et biophysica acta	2013	33
24614104	1499	Tucci V	Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.	The Journal of clinical investigation	2014	26
24736023	1499	Arend RC	Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.	Gynecologic oncology	2014	32
24936790	1499	Cecchelli R	A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells.	PloS one	2014	22
25608619	1499	Zhang Z	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.	Molecular cancer	2015	18
26202299	1499	Jang GB	Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.	Scientific reports	2015	25
26907633	1499	Tagde A	MUC1-C drives MYC in multiple myeloma.	Blood	2016	12
9490748	1536	Keller T	A plant homolog of the neutrophil NADPH oxidase gp91phox subunit gene encodes a plasma membrane protein with Ca2+ binding motifs.	The Plant cell	1998	114
11514595	1536	Edens WA	Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox.	The Journal of cell biology	2001	99
15706079	1536	Van Buul JD	Expression and localization of NOX2 and NOX4 in primary human endothelial cells.	Antioxidants and redox signaling	2005	102
18682599	1536	Mantegazza AR	NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells.	Blood	2008	70
18783311	1536	Pendyala S	Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells.	Antioxidants and redox signaling	2009	67
19523965	1536	Behrens MM	Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?	Neuropharmacology	2009	50
20421951	1536	Miller JL	The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis.	PLoS pathogens	2010	44
20803017	1536	Lam GY	The many roles of NOX2 NADPH oxidase-derived ROS in immunity.	Seminars in immunopathology	2010	45
21278736	1536	Bustamante J	Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.	Nature immunology	2011	58
22713144	1536	Montezano AC	Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.	Annals of medicine	2012	41
24322427	1536	Romao S	Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing.	The Journal of cell biology	2013	27
24916152	1536	Deffert C	Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.	Cellular microbiology	2014	21
24931457	1536	Dhillon SS	Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease.	Gastroenterology	2014	25
25066192	1536	Drummond GR	Endothelial NADPH oxidases: which NOX to target in vascular disease?	Trends in endocrinology and metabolism	2014	35
25564678	1536	Sullivan MN	Localized TRPA1 channel Ca2+ signals stimulated by reactive oxygen species promote cerebral artery dilation.	Science signaling	2015	19
12072369	1604	Triantafilou M	Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster.	Trends in immunology	2002	136
19386604	1604	Thurman JM	Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.	The Journal of biological chemistry	2009	57
21526778	1604	Wiśniewski JR	High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers.	Journal of proteome research	2011	37
11836430	1956	Simmons G	Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.	Journal of virology	2002	85
12359858	1956	Wang F	Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.	Journal of the National Cancer Institute	2002	111
12670923	1956	Aguirre-Ghiso JA	ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).	Cancer research	2003	107
15057284	1956	Qian X	E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.	The EMBO journal	2004	106
15153612	1956	Chen Z	Characterization of putative stem cell phenotype in human limbal epithelia.	Stem cells	2004	116
15158434	1956	Roskoski R Jr	The ErbB/HER receptor protein-tyrosine kinases and cancer.	Biochemical and biophysical research communications	2004	70
15345710	1956	Laederich MB	The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.	The Journal of biological chemistry	2004	75
16361555	1956	Yauch RL	Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.	Clinical cancer research 	2005	161
16424029	1956	Witta SE	Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.	Cancer research	2006	137
16565089	1956	Bourguignon LY	Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.	The Journal of biological chemistry	2006	74
16980555	1956	Zhen G	IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production.	American journal of respiratory cell and molecular biology	2007	74
17146782	1956	Rakha EA	Prognostic markers in triple-negative breast cancer.	Cancer	2007	262
17218988	1956	Kenny PA	Targeting TACE-dependent EGFR ligand shedding in breast cancer.	The Journal of clinical investigation	2007	72
17308052	1956	Buck E	Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition.	Molecular cancer therapeutics	2007	70
17664471	1956	Khambata-Ford S	Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.	Journal of clinical oncology 	2007	291
18317468	1956	Sklar P	Whole-genome association study of bipolar disorder.	Molecular psychiatry	2008	209
18381447	1956	Fuchs BC	Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.	Cancer research	2008	86
19490536	1956	Stuffers S	Multivesicular endosome biogenesis in the absence of ESCRTs.	Traffic	2009	58
19544433	1956	Kelly JJ	Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.	Stem cells	2009	62
20012924	1956	McConkey DJ	Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.	Cancer metastasis reviews	2009	81
20065189	1956	Wells SA Jr	Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.	Journal of clinical oncology 	2010	95
20562913	1956	Gan Y	Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.	Oncogene	2010	73
20798686	1956	Li QQ	Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells.	Cell death and differentiation	2011	40
21273060	1956	Krumbach R	Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance.	European journal of cancer	2011	39
21407195	1956	Maretzky T	Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.	Nature communications	2011	38
21597390	1956	Suda K	Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.	Journal of thoracic oncology 	2011	69
21914172	1956	Sihto H	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.	Breast cancer research 	2011	40
22191652	1956	Zhang Y	PET tracers based on Zirconium-89.	Current radiopharmaceuticals	2011	40
22194472	1956	Ju YS	A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.	Genome research	2012	122
22414764	1956	Blivet-Van Eggelpoël MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	37
22508830	1956	Witta SE	Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.	Journal of clinical oncology 	2012	50
22591372	1956	Gorges TM	Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.	BMC cancer	2012	110
22847020	1956	Phuphanich S	Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.	Cancer immunology, immunotherapy 	2013	68
23070115	1956	Uchida H	Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.	Molecular therapy 	2013	26
23186290	1956	Truong TH	Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation.	Biochemistry	2012	42
23333074	1956	Zaiss DM	Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.	Immunity	2013	49
23470965	1956	Yu HA	Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.	Clinical cancer research 	2013	251
23555746	1956	Luca AC	Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines.	PloS one	2013	36
23645635	1956	Rizvi I	Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.	Proceedings of the National Academy of Sciences of the United States of America	2013	32
23653350	1956	Balanis N	Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.	The Journal of biological chemistry	2013	29
23814043	1956	Gainor JF	Novel targets in non-small cell lung cancer: ROS1 and RET fusions.	The oncologist	2013	35
24747441	1956	Seguin L	An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.	Nature cell biology	2014	58
24939055	1956	Qu Y	Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.	Journal of experimental and clinical cancer research 	2014	22
25629635	1956	Wu C	High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.	Journal of thoracic oncology 	2015	16
25926053	1956	Medico E	The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.	Nature communications	2015	29
26727163	1956	Quoix E	TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.	The Lancet. Oncology	2016	17
1448077	2056	Semenza GL	A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.	Molecular and cellular biology	1992	431
2062846	2056	Semenza GL	Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.	Proceedings of the National Academy of Sciences of the United States of America	1991	144
8408001	2056	Wang GL	Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.	The Journal of biological chemistry	1993	153
8616713	2056	Tripathy SK	Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors.	Nature medicine	1996	117
9718377	2056	Besarab A	The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.	The New England journal of medicine	1998	260
11844847	2056	Casadevall N	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.	The New England journal of medicine	2002	103
12435860	2056	Ehrenreich H	Erythropoietin therapy for acute stroke is both safe and beneficial.	Molecular medicine	2002	162
12663857	2056	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	85
12975460	2056	Villa P	Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis.	The Journal of experimental medicine	2003	103
14525788	2056	Bahlmann FH	Erythropoietin regulates endothelial progenitor cells.	Blood	2004	76
14575968	2056	Henke M	Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.	Lancet	2003	173
15178821	2056	Wang L	Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.	Stroke	2004	196
15247477	2056	Leist M	Derivatives of erythropoietin that are tissue protective but not erythropoietic.	Science	2004	157
15284297	2056	Sharples EJ	Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.	Journal of the American Society of Nephrology 	2004	81
15928718	2056	Brines M	Emerging biological roles for erythropoietin in the nervous system.	Nature reviews. Neuroscience	2005	97
16087945	2056	Leyland-Jones B	Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.	Journal of clinical oncology 	2005	112
16705125	2056	Bohlius J	Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.	Journal of the National Cancer Institute	2006	61
17108342	2056	Drüeke TB	Normalization of hemoglobin level in patients with chronic kidney disease and anemia.	The New England journal of medicine	2006	290
17108343	2056	Singh AK	Correction of anemia with epoetin alfa in chronic kidney disease.	The New England journal of medicine	2006	385
17253966	2056	Jelkmann W	Erythropoietin after a century of research: younger than ever.	European journal of haematology	2007	67
17267743	2056	Inaba M	Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.	Journal of the American Society of Nephrology 	2007	75
17276778	2056	Phrommintikul A	Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.	Lancet	2007	80
17312332	2056	Wright JR	Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.	Journal of clinical oncology 	2007	71
17576662	2056	Westenbrink BD	Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.	European heart journal	2007	56
17804841	2056	Corwin HL	Efficacy and safety of epoetin alfa in critically ill patients.	The New England journal of medicine	2007	82
18314434	2056	Bennett CL	Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.	JAMA	2008	125
18324962	2056	Arcasoy MO	The non-haematopoietic biological effects of erythropoietin.	British journal of haematology	2008	78
18458324	2056	Tong Z	Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.	Proceedings of the National Academy of Sciences of the United States of America	2008	53
19212416	2056	Ashby DR	Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.	Kidney international	2009	50
19410717	2056	Bohlius J	Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.	Lancet	2009	89
19651565	2056	Zhu C	Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.	Pediatrics	2009	61
19833632	2056	Ashby DR	Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.	Haematologica	2010	46
19834012	2056	Ehrenreich H	Recombinant human erythropoietin in the treatment of acute ischemic stroke.	Stroke	2009	145
20064603	2056	Maiese K	Oxidative stress: Biomarkers and novel therapeutic pathways.	Experimental gerontology	2010	41
20164823	2056	Endre ZH	Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).	Kidney international	2010	67
21115615	2056	Bernhardt WM	Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.	Journal of the American Society of Nephrology 	2010	65
21258008	2056	Farha S	Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.	Blood	2011	37
21558517	2056	Najjar SS	Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.	JAMA	2011	53
21898543	2056	Kim J	Erythropoietin mediated bone formation is regulated by mTOR signaling.	Journal of cellular biochemistry	2012	30
22023617	2056	Shang YC	Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia.	Current neurovascular research	2011	40
22678432	2056	Kolarich D	Determination of site-specific glycan heterogeneity on glycoproteins.	Nature protocols	2012	41
23008465	2056	Wu YW	Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.	Pediatrics	2012	46
23281216	2056	Min K	Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.	Stem cells	2013	26
23291219	2056	Haase VH	Regulation of erythropoiesis by hypoxia-inducible factors.	Blood reviews	2013	57
23457296	2056	Bunn HF	Erythropoietin.	Cold Spring Harbor perspectives in medicine	2013	33
24158761	2056	Bachman E	Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.	The journals of gerontology. Series A, Biological sciences and medical sciences	2014	24
25058216	2056	Robertson CS	Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.	JAMA	2014	44
25157725	2056	Leuchter RH	Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.	JAMA	2014	24
25728669	2056	Moraga I	Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands.	Cell	2015	23
26656456	2056	Maxwell PH	HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.	Nature reviews. Nephrology	2016	18
9087410	2147	Ishihara H	Protease-activated receptor 3 is a second thrombin receptor in humans.	Nature	1997	143
10648405	2147	Nieuwland R	Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.	Blood	2000	93
12588269	2147	Lincoff AM	Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.	JAMA	2003	91
17124018	2147	Stone GW	Bivalirudin for patients with acute coronary syndromes.	The New England journal of medicine	2006	110
18499566	2147	Stone GW	Bivalirudin during primary PCI in acute myocardial infarction.	The New England journal of medicine	2008	140
19652875	2147	Jennings LK	Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.	Thrombosis and haemostasis	2009	60
19667878	2147	Park MS	Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.	The Journal of trauma	2009	50
22077816	2147	Tricoci P	Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.	The New England journal of medicine	2012	84
22443427	2147	Morrow DA	Vorapaxar in the secondary prevention of atherothrombotic events.	The New England journal of medicine	2012	90
10079109	2149	Kahn ML	Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.	The Journal of clinical investigation	1999	123
17110453	2149	Mosnier LO	The cytoprotective protein C pathway.	Blood	2007	218
23222541	2149	Zhang C	High-resolution crystal structure of human protease-activated receptor 1.	Nature	2012	104
24092932	2149	Samad F	Inflammation, obesity, and thrombosis.	Blood	2013	32
15254584	2200	Judge DP	Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.	The Journal of clinical investigation	2004	85
17701892	2200	Faivre L	Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.	American journal of human genetics	2007	76
19037100	2200	Sabatier L	Fibrillin assembly requires fibronectin.	Molecular biology of the cell	2009	54
19513754	2200	Ramirez F	Biogenesis and function of fibrillin assemblies.	Cell and tissue research	2010	59
20591885	2200	Loeys BL	The revised Ghent nosology for the Marfan syndrome.	Journal of medical genetics	2010	169
21683322	2200	Le Goff C	Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.	American journal of human genetics	2011	35
21909107	2200	LeMaire SA	Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.	Nature genetics	2011	37
2478233	2214	Passlick B	Identification and characterization of a novel monocyte subpopulation in human peripheral blood.	Blood	1989	186
9078201	2214	Pulliam L	Unique monocyte subset in patients with AIDS dementia.	Lancet	1997	110
11062267	2214	Mahnke K	The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments.	The Journal of cell biology	2000	113
11698225	2214	Cooper MA	The biology of human natural killer-cell subsets.	Trends in immunology	2001	486
11704885	2214	Fischer-Smith T	CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.	Journal of neurovirology	2001	109
14645713	2214	Mavilio D	Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
14734722	2214	Ferlazzo G	The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.	Journal of immunology	2004	110
15269840	2214	Schlitt A	CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.	Thrombosis and haemostasis	2004	76
16203869	2214	Bryceson YT	Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.	The Journal of experimental medicine	2005	137
17135573	2214	Ziegler-Heitbrock L	The CD14+ CD16+ blood monocytes: their role in infection and inflammation.	Journal of leukocyte biology	2007	255
17404276	2214	Romagnani C	CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.	Journal of immunology	2007	119
18203207	2214	Carrega P	Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.	Cancer	2008	68
19278419	2214	Poli A	CD56bright natural killer (NK) cells: an important NK cell subset.	Immunology	2009	96
19573729	2214	Tsujioka H	Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.	Journal of the American College of Cardiology	2009	69
19628705	2214	Bryceson YT	Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.	Blood	2009	58
19965656	2214	Fauriat C	Regulation of human NK-cell cytokine and chemokine production by target cell recognition.	Blood	2010	141
20711229	2214	Zhang J	Natural killer cell-triggered vascular transformation: maternal care before birth?	Cellular and molecular immunology	2011	51
21187373	2214	De Maria A	Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
21242295	2214	Bigley V	The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency.	The Journal of experimental medicine	2011	80
21825173	2214	Lopez-Vergès S	Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.	Proceedings of the National Academy of Sciences of the United States of America	2011	166
22363505	2214	Kamat A	A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.	PloS one	2012	37
22430559	2214	Wong KL	The three human monocyte subsets: implications for health and disease.	Immunologic research	2012	84
22669579	2214	Xu H	IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques.	Mucosal immunology	2012	42
22815256	2214	Matsubara T	TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.	Hepatology	2013	28
22911542	2214	Liaskou E	Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics.	Hepatology	2013	35
23212525	2214	Tel J	Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.	Blood	2013	41
23334791	2214	Bernink JH	Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.	Nature immunology	2013	113
23365694	2214	Martin GE	Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.	PloS one	2013	37
23509156	2214	Reiners KS	Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity.	Blood	2013	41
23690482	2214	Wiernik A	Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.	Clinical cancer research 	2013	44
23760662	2214	Huang A	Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.	Cancer immunology, immunotherapy 	2013	35
24652987	2214	Gleason MK	CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.	Blood	2014	35
24981333	2214	Kwissa M	Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.	Cell host and microbe	2014	30
27117418	2214	Liu LL	Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.	Cell reports	2016	17
1862087	2335	Broekelmann TJ	Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.	Proceedings of the National Academy of Sciences of the United States of America	1991	161
2445780	2335	Nathan CF	Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.	The Journal of clinical investigation	1987	164
3155652	2335	Pytela R	Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor.	Cell	1985	256
7680480	2335	Yamamoto T	Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.	Proceedings of the National Academy of Sciences of the United States of America	1993	133
8335696	2335	DiMilla PA	Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength.	The Journal of cell biology	1993	143
9111868	2335	Naor D	CD44: structure, function, and association with the malignant process.	Advances in cancer research	1997	183
10051240	2335	Salvi S	Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers.	American journal of respiratory and critical care medicine	1999	168
10353737	2335	Brown LF	Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.	Clinical cancer research 	1999	96
10508858	2335	Aguirre Ghiso JA	Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.	The Journal of cell biology	1999	115
10694938	2335	Goodison S	CD44 cell adhesion molecules.	Molecular pathology 	1999	121
10751360	2335	Kim S	Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.	The American journal of pathology	2000	135
11588036	2335	Campagnoli C	Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.	Blood	2001	230
12235007	2335	Gillan L	Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.	Cancer research	2002	147
12451003	2335	Tepper OM	Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.	Circulation	2002	300
12815434	2335	Sakai T	Fibronectin requirement in branching morphogenesis.	Nature	2003	150
14536091	2335	de la Mata M	A slow RNA polymerase II affects alternative splicing in vivo.	Molecular cell	2003	228
15020515	2335	Boldt A	Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease.	Heart	2004	75
15625114	2335	Lau D	Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins.	Proceedings of the National Academy of Sciences of the United States of America	2005	68
16043513	2335	Yoneda A	The Rho kinases I and II regulate different aspects of myosin II activity.	The Journal of cell biology	2005	91
16331674	2335	Grayson WL	Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs.	Journal of cellular physiology	2006	91
16384967	2335	Fleenor DL	TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.	Investigative ophthalmology and visual science	2006	93
16436674	2335	McDaniel SM	Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.	The American journal of pathology	2006	65
16963119	2335	Benoit DS	The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation.	Biomaterials	2007	64
17234776	2335	Yao ES	Increased beta1 integrin is associated with decreased survival in invasive breast cancer.	Cancer research	2007	63
17251138	2335	Metcalfe AD	Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.	Journal of the Royal Society, Interface	2007	62
17546601	2335	Kenny HA	Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.	International journal of cancer	2007	72
17643966	2335	Kim WS	Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts.	Journal of dermatological science	2007	106
17914904	2335	Smith ML	Force-induced unfolding of fibronectin in the extracellular matrix of living cells.	PLoS biology	2007	107
18235537	2335	Riley G	Tendinopathy--from basic science to treatment.	Nature clinical practice. Rheumatology	2008	69
18424525	2335	Valle J	UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli.	Journal of bacteriology	2008	54
18599809	2335	Braam SR	Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin.	Stem cells	2008	98
18602401	2335	Hackel BJ	Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling.	Journal of molecular biology	2008	58
19027948	2335	Martino MM	Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability.	Biomaterials	2009	69
19079190	2335	Blanchard C	Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.	Mucosal immunology	2008	68
19656867	2335	Pandya-Jones A	Co-transcriptional splicing of constitutive and alternative exons.	RNA	2009	86
19875671	2335	Karamichos D	Human corneal fibrosis: an in vitro model.	Investigative ophthalmology and visual science	2010	49
19920174	2335	Chesnokova LS	Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8.	Proceedings of the National Academy of Sciences of the United States of America	2009	70
19940066	2335	Pattabiraman PP	Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells.	American journal of physiology. Cell physiology	2010	45
20133714	2335	Sugii S	Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	48
20507231	2335	Hollands A	Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.	The Journal of infectious diseases	2010	44
20516121	2335	Nam JM	Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.	Cancer research	2010	43
20976230	2335	Williams R	Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage.	PloS one	2010	59
21126355	2335	Szarka A	Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array.	BMC immunology	2010	86
21368175	2335	Antonyak MA	Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	105
22153870	2335	Cheng NC	The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities.	Biomaterials	2012	36
22293174	2335	Salmon H	Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.	The Journal of clinical investigation	2012	37
22451694	2335	Nagae M	Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor.	The Journal of cell biology	2012	45
22472177	2335	DeLay M	Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy.	Clinical cancer research 	2012	36
23047680	2335	Reticker-Flynn NE	A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis.	Nature communications	2012	47
23430739	2335	Thompson CA	Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.	The Journal of biological chemistry	2013	59
24117661	2335	Fernandez-Garcia B	Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.	Histopathology	2014	23
26811325	2335	Oudin MJ	Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.	Cancer discovery	2016	13
9636198	2736	Ricote M	Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.	Proceedings of the National Academy of Sciences of the United States of America	1998	116
10431238	2736	Rust S	Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.	Nature genetics	1999	230
11160388	2736	Combs CK	beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.	The Journal of neuroscience 	2001	132
19281927	2736	Patel S	Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.	Journal of the American College of Cardiology	2009	51
20660365	2736	Alexaki VI	GLI2-mediated melanoma invasion and metastasis.	Journal of the National Cancer Institute	2010	47
22508334	2736	Gao D	1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes.	International journal of obesity	2013	27
9465039	3077	Feder JN	The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.	Proceedings of the National Academy of Sciences of the United States of America	1998	126
15858186	3077	Adams PC	Hemochromatosis and iron-overload screening in a racially diverse population.	The New England journal of medicine	2005	132
16893896	3077	Goswami T	Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing.	The Journal of biological chemistry	2006	95
18199861	3077	Allen KJ	Iron-overload-related disease in HFE hereditary hemochromatosis.	The New England journal of medicine	2008	98
19254567	3077	Gao J	Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.	Cell metabolism	2009	93
19931264	3077	Valenti L	HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.	Gastroenterology	2010	47
3091693	3105	Pober JS	Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.	Journal of immunology	1986	228
10371507	3105	Lee PP	Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.	Nature medicine	1999	201
10602880	3105	Sette A	Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.	Immunogenetics	1999	176
11148222	3105	Goulder PJ	Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.	The Journal of experimental medicine	2001	87
11543903	3105	Cao K	Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations.	Human immunology	2001	94
15592417	3105	Kiepiela P	Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.	Nature	2004	328
16237114	3105	Rosenberg SA	Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.	Journal of immunology	2005	128
18004301	3105	Nejentsev S	Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.	Nature	2007	140
18366636	3105	Lin HH	Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research.	BMC immunology	2008	81
18953350	3105	Friese MA	Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.	Nature medicine	2008	50
19368562	3105	Apps R	Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies.	Immunology	2009	58
20870028	3105	Woolfrey A	HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.	Biology of blood and marrow transplantation 	2011	42
21149285	3105	Ozeki T	Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.	Human molecular genetics	2011	57
21873457	3105	Chazara O	Maternal KIR and fetal HLA-C: a fine balance.	Journal of leukocyte biology	2011	40
22418738	3105	Dutoit V	Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.	Brain 	2012	34
23741009	3105	Torikai H	Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.	Blood	2013	37
23770775	3105	Linette GP	Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.	Blood	2013	168
23926201	3105	Cameron BJ	Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.	Science translational medicine	2013	103
24046013	3105	Fürst D	High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.	Blood	2013	25
25754738	3105	Apps R	Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells.	Journal of immunology	2015	18
25837513	3105	Carreno BM	Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.	Science	2015	95
26267621	3105	Petersdorf EW	High HLA-DP Expression and Graft-versus-Host Disease.	The New England journal of medicine	2015	19
2257626	3106	Hammer RE	Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.	Cell	1990	148
7964509	3106	Taurog JD	The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.	The Journal of experimental medicine	1994	202
8770866	3106	Rath HC	Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.	The Journal of clinical investigation	1996	147
9433870	3106	Braun J	Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.	Arthritis and rheumatism	1998	113
11386265	3106	Gao X	Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.	The New England journal of medicine	2001	139
11460164	3106	Goulder PJ	Evolution and transmission of stable CTL escape mutations in HIV infection.	Nature	2001	205
11888582	3106	Mallal S	Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.	Lancet	2002	178
11943262	3106	Hetherington S	Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.	Lancet	2002	107
12768008	3106	Migueles SA	The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.	Journal of virology	2003	77
14574404	3106	Mungall AJ	The DNA sequence and analysis of human chromosome 6.	Nature	2003	75
15067030	3106	Draenert R	Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.	The Journal of experimental medicine	2004	140
15743917	3106	Hung SI	HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.	Proceedings of the National Academy of Sciences of the United States of America	2005	122
16369537	3106	Frahm N	Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.	Nature immunology	2006	101
16682496	3106	Bailey JR	Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.	The Journal of experimental medicine	2006	123
17496894	3106	Martin MP	Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.	Nature genetics	2007	273
17641165	3106	Fellay J	A whole-genome association study of major determinants for host control of HIV-1.	Science	2007	503
17892322	3106	Lewinsohn DA	Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.	PLoS pathogens	2007	57
18192896	3106	Lonjou C	A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.	Pharmacogenetics and genomics	2008	62
18256392	3106	Mallal S	HLA-B*5701 screening for hypersensitivity to abacavir.	The New England journal of medicine	2008	262
18353945	3106	Emu B	HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.	Journal of virology	2008	117
18444831	3106	Saag M	High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.	Clinical infectious diseases 	2008	67
19109381	3106	Boutwell CL	Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein.	Journal of virology	2009	50
19242411	3106	Kawashima Y	Adaptation of HIV-1 to human leukocyte antigen class I.	Nature	2009	187
19248087	3106	Rudwaleit M	The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.	Arthritis and rheumatism	2009	60
19307327	3106	Crawford H	Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.	The Journal of experimental medicine	2009	100
19696695	3106	Tassaneeyakul W	Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.	Pharmacogenetics and genomics	2009	51
19944697	3106	Karlsen TH	Genome-wide association analysis in primary sclerosing cholangitis.	Gastroenterology	2010	54
20064448	3106	Macdonald WA	T cell allorecognition via molecular mimicry.	Immunity	2009	82
20205591	3106	Pelak K	Host determinants of HIV-1 control in African Americans.	The Journal of infectious diseases	2010	68
20523897	3106	Hersperger AR	Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.	PLoS pathogens	2010	134
20616031	3106	Gras S	Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.	Proceedings of the National Academy of Sciences of the United States of America	2010	54
21162721	3106	Harr T	Toxic epidermal necrolysis and Stevens-Johnson syndrome.	Orphanet journal of rare diseases	2010	60
21248258	3106	Bowness P	Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.	Journal of immunology	2011	50
21868630	3106	Abi-Rached L	The shaping of modern human immune systems by multiregional admixture with archaic humans.	Science	2011	86
22020283	3106	Vivian JP	Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.	Nature	2011	78
22102287	3106	Wooldridge L	A single autoimmune T cell receptor recognizes more than a million different peptides.	The Journal of biological chemistry	2012	87
22231483	3106	Iqbal Z	De novo assembly and genotyping of variants using colored de Bruijn graphs.	Nature genetics	2012	128
22322005	3106	Wei CY	Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.	The Journal of allergy and clinical immunology	2012	37
22378157	3106	Martin MA	Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.	Clinical pharmacology and therapeutics	2012	41
22683743	3106	Chen H	TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.	Nature immunology	2012	83
22999948	3106	Goulder PJ	HIV and HLA class I: an evolving relationship.	Immunity	2012	74
23023123	3106	Mudd PA	Vaccine-induced CD8+ T cells control AIDS virus replication.	Nature	2012	76
23505240	3106	Baraliakos X	Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.	Annals of the rheumatic diseases	2014	28
23956249	3106	Ramiro S	Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.	Annals of the rheumatic diseases	2015	16
23993278	3106	Colbert RA	HLA-B27 misfolding and ankylosing spondylitis.	Molecular immunology	2014	23
25140823	3106	Lin P	HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.	PloS one	2014	28
26439405	3106	Brown MA	Genetics of ankylosing spondylitis--insights into pathogenesis.	Nature reviews. Rheumatology	2016	14
10403641	3107	Cohen GB	The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.	Immunity	1999	283
10611338	3107	Davis DM	The human natural killer cell immune synapse.	Proceedings of the National Academy of Sciences of the United States of America	1999	97
12114532	3107	Drukker M	Characterization of the expression of MHC proteins in human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	118
15356110	3107	Barber DF	LFA-1 contributes an early signal for NK cell cytotoxicity.	Journal of immunology	2004	77
15731175	3107	Hsu KC	Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.	Blood	2005	116
19935663	3107	Thomas R	HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.	Nature genetics	2009	101
22772445	3107	Hilton HG	Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.	Journal of immunology	2012	33
22883433	3107	Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2.	Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia.	Biological psychiatry	2012	46
22931314	3107	Venstrom JM	HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.	The New England journal of medicine	2012	103
23559252	3107	Apps R	Influence of HLA-C expression level on HIV control.	Science	2013	85
23613577	3107	López-Sagaseta J	The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
24748496	3107	Cooley S	Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.	Journal of immunology	2014	29
26490195	3107	Cleynen I	Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.	Lancet	2016	40
26516200	3107	Tran E	Immunogenicity of somatic mutations in human gastrointestinal cancers.	Science	2015	61
19596691	3115	Arnett FC	Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.	Annals of the rheumatic diseases	2010	47
21092157	3115	Wang P	Peptide binding predictions for HLA DR, DP and DQ molecules.	BMC bioinformatics	2010	101
21274863	3115	Guo X	Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.	Hepatology	2011	37
22340965	3115	Fleischhauer K	Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.	The Lancet. Oncology	2012	49
23762245	3115	Jia X	Imputing amino acid polymorphisms in human leukocyte antigens.	PloS one	2013	110
23900783	3115	Karosiene E	NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.	Immunogenetics	2013	49
25056373	3115	Koido S	Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.	Clinical cancer research 	2014	22
25161269	3115	Pidala J	Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.	Blood	2014	22
3174659	3117	Gyllensten UB	Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.	Proceedings of the National Academy of Sciences of the United States of America	1988	242
3785382	3117	Saiki RK	Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.	Nature	1986	253
12651074	3117	Karell K	HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.	Human immunology	2003	90
18252895	3117	Erlich H	HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.	Diabetes	2008	165
20639878	3117	Singer JB	A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.	Nature genetics	2010	72
20798335	3117	Noble JA	HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.	Diabetes	2010	42
21245432	3117	Spraggs CF	HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.	Journal of clinical oncology 	2011	49
22455414	3117	Tekola Ayele F	HLA class II locus and susceptibility to podoconiosis.	The New England journal of medicine	2012	43
25349203	3117	Gbadegesin RA	HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.	Journal of the American Society of Nephrology 	2015	16
12374492	3119	Mignot E	The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.	Archives of neurology	2002	122
14669136	3119	Oksenberg JR	Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.	American journal of human genetics	2004	81
18814906	3119	Näntö-Salonen K	Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.	Lancet	2008	74
19458352	3119	Hirschfield GM	Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.	The New England journal of medicine	2009	153
19522996	3119	Erkkola M	Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children.	Clinical and experimental allergy 	2009	73
20719952	3119	Ferre AL	HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.	Journal of virology	2010	44
22470463	3119	Partinen M	Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.	PloS one	2012	61
24550192	3119	Kallionpää H	Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility.	Diabetes	2014	27
25710614	3119	Hong X	Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children.	Nature communications	2015	15
12244309	3123	Lang HL	A functional and structural basis for TCR cross-reactivity in multiple sclerosis.	Nature immunology	2002	91
12436116	3123	Kotb M	An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections.	Nature medicine	2002	88
12847215	3123	Hill JA	Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.	Journal of immunology	2003	128
14519705	3123	Norris JM	Timing of initial cereal exposure in infancy and risk of islet autoimmunity.	JAMA	2003	102
16014670	3123	Linn-Rasker SP	Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.	Annals of the rheumatic diseases	2006	60
16255021	3123	Huizinga TW	Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.	Arthritis and rheumatism	2005	107
16572446	3123	van der Helm-van Mil AH	The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.	Arthritis and rheumatism	2006	69
16698940	3123	Ashwood P	The immune response in autism: a new frontier for autism research.	Journal of leukocyte biology	2006	104
17266100	3123	Gonzalez-Gay MA	HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.	Arthritis and rheumatism	2007	65
17505501	3123	Kindmark A	Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis.	The pharmacogenomics journal	2008	66
19151010	3123	Karlson EW	Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis.	Annals of the rheumatic diseases	2010	56
21149499	3123	Källberg H	Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke.	Annals of the rheumatic diseases	2011	68
21982422	3123	Eapen M	Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.	The Lancet. Oncology	2011	41
22429309	3123	Wiebe C	Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.	American journal of transplantation 	2012	92
23136186	3123	Weldon JE	A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity.	Molecular cancer therapeutics	2013	31
24190431	3123	Scally SW	A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis.	The Journal of experimental medicine	2013	59
24817415	3123	Ytterberg AJ	Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.	Annals of the rheumatic diseases	2015	16
9480992	3133	Borrego F	Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.	The Journal of experimental medicine	1998	116
18069056	3133	Wilkinson GW	Modulation of natural killer cells by human cytomegalovirus.	Journal of clinical virology 	2008	88
21054940	3133	Deuse T	Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.	Cell transplantation	2011	49
21057081	3133	de Kruijf EM	HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.	Journal of immunology	2010	45
24196788	3133	Zeestraten EC	Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.	British journal of cancer	2014	28
26828202	3133	Davis ZB	A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.	PLoS pathogens	2016	17
2326636	3135	Kovats S	A class I antigen, HLA-G, expressed in human trophoblasts.	Science	1990	176
10190900	3135	Rajagopalan S	A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.	The Journal of experimental medicine	1999	110
17667815	3135	Nasef A	Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.	Transplantation	2007	74
17847008	3135	Tan Z	Allele-specific targeting of microRNAs to HLA-G and risk of asthma.	American journal of human genetics	2007	114
17932417	3135	Selmani Z	Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.	Stem cells	2008	197
18703664	3135	Weiss ML	Immune properties of human umbilical cord Wharton's jelly-derived cells.	Stem cells	2008	100
21107637	3135	Donadi EA	Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.	Cellular and molecular life sciences 	2011	46
25418726	3135	Feng Q	Scalable generation of universal platelets from human induced pluripotent stem cells.	Stem cell reports	2014	32
8855140	3240	Langlois MR	Biological and clinical significance of haptoglobin polymorphism in humans.	Clinical chemistry	1996	124
18032779	3240	Milman U	Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.	Arteriosclerosis, thrombosis, and vascular biology	2008	75
19805376	3240	Tripathi A	Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
21214223	3240	Arnold JN	Novel glycan biomarkers for the detection of lung cancer.	Journal of proteome research	2011	49
22922649	3240	Andersen CB	Structure of the haptoglobin-haemoglobin complex.	Nature	2012	44
23264591	3240	Schaer DJ	Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.	Blood	2013	97
23389048	3240	Sanda M	Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.	Molecular and cellular proteomics 	2013	28
23965626	3240	Uzureau P	Mechanism of Trypanosoma brucei gambiense resistance to human serum.	Nature	2013	36
26694989	3240	Schaer CA	Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis.	American journal of respiratory and critical care medicine	2016	10
1361507	3383	Ades EW	HMEC-1: establishment of an immortalized human microvascular endothelial cell line.	The Journal of investigative dermatology	1992	283
1675157	3383	Diamond MS	Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.	Cell	1991	157
2538243	3383	Greve JM	The major human rhinovirus receptor is ICAM-1.	Cell	1989	245
2566624	3383	Smith CW	Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.	The Journal of clinical investigation	1989	203
3086451	3383	Dustin ML	Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).	Journal of immunology	1986	365
3525675	3383	Rothlein R	A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.	Journal of immunology	1986	225
7499828	3383	Yao Z	Human IL-17: a novel cytokine derived from T cells.	Journal of immunology	1995	195
7542286	3383	De Caterina R	Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.	The Journal of clinical investigation	1995	226
8476577	3383	Bevilacqua MP	Endothelial-leukocyte adhesion molecules.	Annual review of immunology	1993	186
9347951	3383	Newbold C	Receptor-specific adhesion and clinical disease in Plasmodium falciparum.	The American journal of tropical medicine and hygiene	1997	117
9416885	3383	Hwang SJ	Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.	Circulation	1997	188
9453485	3383	D'Haens GR	Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.	Gastroenterology	1998	110
10393703	3383	Combes V	In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.	The Journal of clinical investigation	1999	124
10545519	3383	Peled A	The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.	The Journal of clinical investigation	1999	113
11108718	3383	Kim I	Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.	The Journal of biological chemistry	2001	142
11566912	3383	Chae CU	Blood pressure and inflammation in apparently healthy men.	Hypertension	2001	102
11854119	3383	Ziccardi P	Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.	Circulation	2002	131
11923038	3383	Nappo F	Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.	Journal of the American College of Cardiology	2002	90
15021878	3383	Schenkel AR	Locomotion of monocytes on endothelium is a critical step during extravasation.	Nature immunology	2004	103
15113816	3383	Meigs JB	Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.	JAMA	2004	128
15731292	3383	Benito MJ	Synovial tissue inflammation in early and late osteoarthritis.	Annals of the rheumatic diseases	2005	143
15811956	3383	Yang L	ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.	Blood	2005	150
16394262	3383	Taylor KR	Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation.	FASEB journal 	2006	119
16429128	3383	Millán J	Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains.	Nature cell biology	2006	104
16636195	3383	Hattori Y	Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.	Hypertension	2006	102
16935624	3383	Huang J	Inflammation in stroke and focal cerebral ischemia.	Surgical neurology	2006	133
16973825	3383	Csiszar A	Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.	American journal of physiology. Heart and circulatory physiology	2006	88
17112620	3383	Giulietti A	Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.	Diabetes research and clinical practice	2007	58
17182639	3383	O'Neill MS	Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.	Occupational and environmental medicine	2007	77
17347663	3383	d'Aquino R	Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation.	Cell death and differentiation	2007	86
19118698	3383	Funatsu H	Association of vitreous inflammatory factors with diabetic macular edema.	Ophthalmology	2009	52
19307690	3383	Lawson C	ICAM-1 signaling in endothelial cells.	Pharmacological reports 	2009	133
19560161	3383	Steppan J	Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix.	The Journal of surgical research	2011	38
19587009	3383	Podgrabinska S	Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism.	Journal of immunology	2009	54
19909745	3383	Mlecnik B	Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.	Gastroenterology	2010	71
19949084	3383	Suárez Y	Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation.	Journal of immunology	2010	82
20080853	3383	Russell M	Visceral fat is a negative predictor of bone density measures in obese adolescent girls.	The Journal of clinical endocrinology and metabolism	2010	60
20585554	3383	Paré G	On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study.	PLoS genetics	2010	54
20824088	3383	Joergensen L	Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1.	PLoS pathogens	2010	41
21164106	3383	Rautou PE	Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration.	Circulation research	2011	40
21390226	3383	Ochola LB	Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.	PloS one	2011	55
21448265	3383	Meijer K	Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages.	PloS one	2011	52
21478334	3383	Lohr J	Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.	Clinical cancer research 	2011	48
21483405	3383	Bochkov YA	Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C.	Nature medicine	2011	64
21727908	3383	Chen T	Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients.	Cell research	2012	37
22015609	3383	Kim JY	Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques.	Cell death and differentiation	2012	30
22016448	3383	Richards TJ	Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.	American journal of respiratory and critical care medicine	2012	75
22744718	3383	Chalmers JD	Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.	American journal of respiratory and critical care medicine	2012	30
23148992	3383	Bose CL	Systemic inflammation associated with mechanical ventilation among extremely preterm infants.	Cytokine	2013	28
23376424	3383	Liu S	Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.	Gastroenterology	2013	29
23524845	3383	Skibsted S	Biomarkers of endothelial cell activation in early sepsis.	Shock	2013	25
24135142	3383	Ghaedi M	Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix.	The Journal of clinical investigation	2013	49
24385016	3383	Bind MA	Air pollution and gene-specific methylation in the Normative Aging Study: association, effect modification, and mediation analysis.	Epigenetics	2014	25
24471509	3383	Kennedy JL	Comparison of viral load in individuals with and without asthma during infections with rhinovirus.	American journal of respiratory and critical care medicine	2014	22
26152369	3383	O'Carroll SJ	Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells.	Journal of neuroinflammation	2015	20
1672545	3458	Chan SH	Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.	The Journal of experimental medicine	1991	182
3926894	3458	Shalaby MR	Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.	Journal of immunology	1985	172
8102388	3458	D'Andrea A	Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.	The Journal of experimental medicine	1993	292
9176497	3458	Döcke WD	Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.	Nature medicine	1997	203
9294140	3458	Lalvani A	Rapid effector function in CD8+ memory T cells.	The Journal of experimental medicine	1997	171
9366401	3458	Steinbrink K	Induction of tolerance by IL-10-treated dendritic cells.	Journal of immunology	1997	220
10201989	3458	Fehniger TA	Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.	Journal of immunology	1999	129
10226067	3458	Baldini M	A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.	American journal of respiratory cell and molecular biology	1999	125
10428293	3458	Frostegård J	Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.	Atherosclerosis	1999	141
10479160	3458	Day NP	The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria.	The Journal of infectious diseases	1999	99
10646872	3458	Jaiswal M	Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.	Cancer research	2000	104
10725715	3458	Hwu P	Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.	Journal of immunology	2000	131
10880527	3458	Appay V	HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.	The Journal of experimental medicine	2000	201
10955814	3458	Ueno T	Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.	Clinical cancer research 	2000	160
11406550	3458	Woo EY	Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.	Cancer research	2001	243
11673535	3458	Pathan AA	Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.	Journal of immunology	2001	103
11717429	3458	Bennett BL	SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.	Proceedings of the National Academy of Sciences of the United States of America	2001	591
12147537	3458	Adrie C	Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome.	Circulation	2002	113
12438348	3458	Bacellar O	Up-regulation of Th1-type responses in mucosal leishmaniasis patients.	Infection and immunity	2002	100
12750172	3458	Dufour C	TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.	Blood	2003	82
12960359	3458	Morgan RA	High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.	Journal of immunology	2003	77
15589309	3458	Dorman SE	Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.	Lancet	2004	89
15710900	3458	Mohamadzadeh M	Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization.	Proceedings of the National Academy of Sciences of the United States of America	2005	87
15864738	3458	Klyushnenkova E	T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.	Journal of biomedical science	2005	97
16258194	3458	Arican O	Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.	Mediators of inflammation	2005	91
16330536	3458	Verreck FA	Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.	Journal of leukocyte biology	2006	91
16542361	3458	Ribeiro-Rodrigues R	A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis.	Clinical and experimental immunology	2006	68
16543949	3458	Amedei A	The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.	The Journal of clinical investigation	2006	70
16971810	3458	Palucka AK	Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.	Journal of immunotherapy	2006	71
17255300	3458	Ochoa AC	Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.	Clinical cancer research 	2007	133
17339431	3458	Bogiatzi SI	Cutting Edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes.	Journal of immunology	2007	59
17513768	3458	Martineau AR	IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.	Journal of immunology	2007	100
17553885	3458	Kannanganat S	Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.	Journal of virology	2007	114
17709496	3458	Jones S	The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells.	Journal of immunology	2007	63
17916356	3458	Dolganiuc A	Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.	Gastroenterology	2007	65
18039949	3458	Zaba LC	Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.	The Journal of experimental medicine	2007	134
18292584	3458	Soares AP	Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.	Journal of immunology	2008	81
18497880	3458	Kamada N	Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.	The Journal of clinical investigation	2008	139
18678243	3458	Reale M	Peripheral cytokines profile in Parkinson's disease.	Brain, behavior, and immunity	2009	75
18840671	3458	Spencer LA	Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.	Journal of leukocyte biology	2009	65
19017986	3458	Bertholet S	Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.	Journal of immunology	2008	52
19029905	3458	Cupedo T	Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells.	Nature immunology	2009	149
19088044	3458	Kusmartsev S	Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.	Clinical cancer research 	2008	83
19251324	3458	Brietzke E	Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.	Journal of affective disorders	2009	46
19330474	3458	Wolk K	IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.	Journal of molecular medicine	2009	58
19487422	3458	Strowig T	Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.	The Journal of experimental medicine	2009	92
19497992	3458	Moodley Y	Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.	The American journal of pathology	2009	77
19536809	3458	Xu Q	Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.	Stem cells	2009	54
19724208	3458	Massingale ML	Analysis of inflammatory cytokines in the tears of dry eye patients.	Cornea	2009	81
19890056	3458	Jäger A	Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.	Journal of immunology	2009	186
20015486	3458	Dowlati Y	A meta-analysis of cytokines in major depression.	Biological psychiatry	2010	516
20194818	3458	Wright RJ	Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.	American journal of respiratory and critical care medicine	2010	58
20339534	3458	Waddell SJ	Dissecting interferon-induced transcriptional programs in human peripheral blood cells.	PloS one	2010	58
20400682	3458	Maslak PG	Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.	Blood	2010	43
20437580	3458	Bar-Or A	Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?	Annals of neurology	2010	85
20491796	3458	Harris J	How tumour necrosis factor blockers interfere with tuberculosis immunity.	Clinical and experimental immunology	2010	52
21085185	3458	Chiricozzi A	Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.	The Journal of investigative dermatology	2011	77
22323453	3458	Gleason MK	Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.	Blood	2012	58
22378844	3458	Trotta R	miR-155 regulates IFN-γ production in natural killer cells.	Blood	2012	61
22466287	3458	Zielinski CE	Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.	Nature	2012	190
22539471	3458	Singh OP	Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.	Clinical and vaccine immunology 	2012	33
22569268	3458	Kamat A	Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.	Journal of acquired immune deficiency syndromes	2012	61
22983442	3458	Romee R	Cytokine activation induces human memory-like NK cells.	Blood	2012	82
23271808	3458	Fu B	Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
23468501	3458	Jegaskanda S	Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.	Journal of virology	2013	47
23493728	3458	Jarvis JN	The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.	The Journal of infectious diseases	2013	29
23592910	3458	Kutty RK	Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ.	Molecular vision	2013	27
23867552	3458	Carreno BM	IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.	The Journal of clinical investigation	2013	37
23915137	3458	Swindell WR	Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.	BMC genomics	2013	34
23999600	3458	Garg A	HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.	The Journal of infectious diseases	2014	22
24219905	3458	Zimmermann JA	Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.	Cytotherapy	2014	26
24442432	3458	Della Chiesa M	Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.	Journal of immunology	2014	31
25211344	3458	Sedegah M	Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.	PloS one	2014	25
25329659	3458	Luetke-Eversloh M	Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells.	PLoS pathogens	2014	34
25469528	3458	Villar-García J	Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.	Journal of acquired immune deficiency syndromes	2015	26
25534940	3458	Cardoso TM	Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.	Infection and immunity	2015	16
25644696	3458	Jiang W	Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.	Scientific reports	2015	23
26405286	3458	Getahun H	Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.	The European respiratory journal	2015	21
27068708	3458	Fletcher HA	T-cell activation is an immune correlate of risk in BCG vaccinated infants.	Nature communications	2016	16
1655948	3552	de Waal Malefyt R	Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.	The Journal of experimental medicine	1991	343
1978068	3552	Kwiatkowski D	TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.	Lancet	1990	205
2065663	3552	Schreck R	Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.	The EMBO journal	1991	506
2294996	3552	Schindler R	Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.	Blood	1990	149
2494664	3552	Osborn L	Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.	Proceedings of the National Academy of Sciences of the United States of America	1989	423
2783334	3552	Waage A	The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.	The Journal of experimental medicine	1989	198
7735624	3552	Humbert M	Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.	American journal of respiratory and critical care medicine	1995	125
10920188	3552	Bowie A	A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.	Proceedings of the National Academy of Sciences of the United States of America	2000	139
10936147	3552	Dinarello CA	Proinflammatory cytokines.	Chest	2000	269
11527941	3552	Solomon A	Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.	Investigative ophthalmology and visual science	2001	135
12220547	3552	Arend WP	The balance between IL-1 and IL-1Ra in disease.	Cytokine and growth factor reviews	2002	140
12433676	3552	Nemeth E	Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.	Blood	2003	253
12522051	3552	de Jager W	Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells.	Clinical and diagnostic laboratory immunology	2003	105
15851489	3552	Pascual V	Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.	The Journal of experimental medicine	2005	174
16564013	3552	Janes KA	The response of human epithelial cells to TNF involves an inducible autocrine cascade.	Cell	2006	84
17688691	3552	Le Maitre CL	Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile.	Arthritis research and therapy	2007	118
18258476	3552	Blanco P	Dendritic cells and cytokines in human inflammatory and autoimmune diseases.	Cytokine and growth factor reviews	2008	88
18982160	3552	Brennan FM	Evidence that cytokines play a role in rheumatoid arthritis.	The Journal of clinical investigation	2008	169
19428098	3552	Lopez-Souza N	In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects.	The Journal of allergy and clinical immunology	2009	61
19785746	3552	de Jager W	Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.	BMC immunology	2009	70
20110505	3552	Boilard E	Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.	Science	2010	197
21211650	3552	Baines KJ	Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples.	The Journal of allergy and clinical immunology	2011	38
22566778	3552	Rubio-Perez JM	A review: inflammatory process in Alzheimer's disease, role of cytokines.	TheScientificWorldJournal	2012	123
22739623	3552	Lambertsen KL	Inflammatory cytokines in experimental and human stroke.	Journal of cerebral blood flow and metabolism 	2012	105
23922312	3552	Bartosh TJ	Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1).	Stem cells	2013	29
28099414	3552	Liddelow SA	Neurotoxic reactive astrocytes are induced by activated microglia.	Nature	2017	36
2835680	3553	Michie HR	Detection of circulating tumor necrosis factor after endotoxin administration.	The New England journal of medicine	1988	218
8403503	3553	Reinecker HC	Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.	Clinical and experimental immunology	1993	157
8520783	3553	Bonfield TL	Inflammatory cytokines in cystic fibrosis lungs.	American journal of respiratory and critical care medicine	1995	150
9141509	3553	Vgontzas AN	Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.	The Journal of clinical endocrinology and metabolism	1997	141
9240577	3553	Yoon BH	Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.	American journal of obstetrics and gynecology	1997	116
9531313	3553	Jovanovic DV	IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.	Journal of immunology	1998	209
9925898	3553	Ostrowski K	Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans.	The Journal of physiology	1999	105
10358063	3553	Nath A	Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon.	The Journal of biological chemistry	1999	105
10430608	3553	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	106
10608764	3553	Gogos CA	Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.	The Journal of infectious diseases	2000	116
10617994	3553	James MJ	Dietary polyunsaturated fatty acids and inflammatory mediator production.	The American journal of clinical nutrition	2000	126
11058758	3553	Fournier T	Alpha-1-acid glycoprotein.	Biochimica et biophysica acta	2000	114
11263773	3553	Tetlow LC	Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.	Arthritis and rheumatism	2001	120
11489912	3553	Lindemann S	Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.	The Journal of cell biology	2001	97
11734443	3553	Park WY	Cytokine balance in the lungs of patients with acute respiratory distress syndrome.	American journal of respiratory and critical care medicine	2001	102
12606524	3553	Spranger J	Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.	Diabetes	2003	249
12891537	3553	Machado JC	A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma.	Gastroenterology	2003	106
12957433	3553	Gielen S	Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.	Journal of the American College of Cardiology	2003	81
14581396	3553	Mazurek T	Human epicardial adipose tissue is a source of inflammatory mediators.	Circulation	2003	266
14662866	3553	Cowland JB	Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha.	Journal of immunology	2003	75
15198989	3553	Li J	Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.	Human molecular genetics	2004	72
15240608	3553	Malkin CJ	The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.	The Journal of clinical endocrinology and metabolism	2004	96
15671098	3553	Bruun JM	Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.	The Journal of clinical endocrinology and metabolism	2005	91
15910952	3553	van Heel DA	Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.	Lancet	2005	75
16037403	3553	Shah JP	An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle.	Journal of applied physiology	2005	79
16202406	3553	Li DQ	JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells.	Experimental eye research	2006	71
16284605	3553	Demircan N	Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.	Eye	2006	76
16785446	3553	Chae JJ	The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17291458	3553	Shakibaei M	Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.	Biochemical pharmacology	2007	65
17383420	3553	Liebregts T	Immune activation in patients with irritable bowel syndrome.	Gastroenterology	2007	101
17636564	3553	Nesbitt A	Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.	Inflammatory bowel diseases	2007	60
17853946	3553	Schenk M	TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.	The Journal of clinical investigation	2007	73
18164325	3553	Shah JP	Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points.	Archives of physical medicine and rehabilitation	2008	76
18262644	3553	Challier JC	Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta.	Placenta	2008	129
18397957	3553	Hoyland JA	Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc.	Rheumatology	2008	62
19008124	3553	Jones SW	The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13.	Osteoarthritis and cartilage	2009	76
19085934	3553	Slominski A	Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.	International journal of cancer	2009	48
19171879	3553	Beriou G	IL-17-producing human peripheral regulatory T cells retain suppressive function.	Blood	2009	118
19248089	3553	Wehling N	Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways.	Arthritis and rheumatism	2009	51
19255163	3553	Chotikavanich S	Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome.	Investigative ophthalmology and visual science	2009	69
19714579	3553	Miyaki S	MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses.	Arthritis and rheumatism	2009	83
19895991	3553	Zaba LC	Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.	The Journal of allergy and clinical immunology	2009	63
20064793	3553	Samberg ME	Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro.	Environmental health perspectives	2010	52
20522023	3553	Barbarroja N	The obese healthy paradox: is inflammation the answer?	The Biochemical journal	2010	40
20545607	3553	Goldberg JE	Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics.	Current drug targets	2010	55
21486440	3553	Soria G	Inflammatory mediators in breast cancer: coordinated expression of TNFα &amp;amp; IL-1β with CCL2 &amp;amp; CCL5 and effects on epithelial-to-mesenchymal transition.	BMC cancer	2011	64
21700772	3553	Wang JG	Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.	Blood	2011	55
21872339	3553	Liu Y	Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.	Journal of affective disorders	2012	88
21949132	3553	Wang J	TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.	The Journal of biological chemistry	2011	37
22219513	3553	Csiszar A	Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	39
22925832	3553	Rethorst CD	Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.	Molecular psychiatry	2013	29
23110185	3553	Keshari RS	Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition.	PloS one	2012	31
23143332	3553	Zhu W	Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability.	Nature	2012	36
23360282	3553	Gola H	Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells.	BMC psychiatry	2013	33
23630220	3553	Jaremka LM	Loneliness promotes inflammation during acute stress.	Psychological science	2013	28
23954649	3553	Garcia JM	Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.	Clinical gastroenterology and hepatology 	2014	25
24225954	3553	Bretz NP	Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling.	The Journal of biological chemistry	2013	37
24470004	3553	Kiecolt-Glaser JK	Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial.	Journal of clinical oncology 	2014	25
24497828	3553	Sereti I	Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.	PLoS pathogens	2014	32
24554772	3553	Samstad EO	Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.	Journal of immunology	2014	37
24876674	3553	Wojdasiewicz P	The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.	Mediators of inflammation	2014	58
24901329	3553	Kumar RG	Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.	The Journal of head trauma rehabilitation	2015	27
24920309	3553	Jansson D	A role for human brain pericytes in neuroinflammation.	Journal of neuroinflammation	2014	20
25057045	3553	Dinh DM	Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.	The Journal of infectious diseases	2015	56
25412102	3553	Escudero-Pérez B	Shed GP of Ebola virus triggers immune activation and increased vascular permeability.	PLoS pathogens	2014	26
25649144	3553	Crișan TO	Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra.	Annals of the rheumatic diseases	2016	13
26187413	3553	Bernink JH	Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.	Immunity	2015	37
26668389	3553	Kim HJ	Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.	Proceedings of the National Academy of Sciences of the United States of America	2016	39
26903267	3553	Goldsmith DR	A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.	Molecular psychiatry	2016	24
6975347	3558	Robb RJ	T cell growth factor receptors. Quantitation, specificity, and biological relevance.	The Journal of experimental medicine	1981	224
7523571	3558	Carson WE	Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.	The Journal of experimental medicine	1994	200
9500606	3558	Rosenberg SA	Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.	Nature medicine	1998	274
10699311	3558	Sudimack J	Targeted drug delivery via the folate receptor.	Advanced drug delivery reviews	2000	117
11565838	3558	Dudley ME	Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.	Journal of immunotherapy	2001	108
11675346	3558	Ng WF	Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.	Blood	2001	100
12427970	3558	Yee C	Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	320
12480696	3558	Fehniger TA	CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.	Blood	2003	179
12843795	3558	Dudley ME	Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.	Journal of immunotherapy	2003	157
15218108	3558	Sivori S	CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	87
15780987	3558	Freud AG	A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.	Immunity	2005	99
16007258	3558	Valmori D	A peripheral circulating compartment of natural naive CD4 Tregs.	The Journal of clinical investigation	2005	96
16051844	3558	Brooks DG	Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection.	Journal of virology	2005	82
16121185	3558	Watanabe N	Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.	Nature	2005	162
16567385	3558	Jabbari A	Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.	The Journal of experimental medicine	2006	83
17025272	3558	Kreitman RJ	Immunotoxins for targeted cancer therapy.	The AAPS journal	2006	68
19364969	3558	Sabatino M	Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.	Journal of clinical oncology 	2009	49
20491785	3558	Meraviglia S	In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.	Clinical and experimental immunology	2010	57
20736326	3558	Jacobs JF	Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.	Clinical cancer research 	2010	50
20921469	3558	Shusterman S	Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.	Journal of clinical oncology 	2010	61
20935224	3558	Delgado DC	Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	Cancer research	2010	50
20951793	3558	Janelidze S	Cytokine levels in the blood may distinguish suicide attempters from depressed patients.	Brain, behavior, and immunity	2011	44
21521467	3558	Thompson P	CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.	American journal of transplantation 	2011	39
21771874	3558	Lesterhuis WJ	Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.	Clinical cancer research 	2011	39
2261637	3569	Hibi M	Molecular cloning and expression of an IL-6 signal transducer, gp130.	Cell	1990	190
8609343	3569	Torre-Amione G	Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).	Journal of the American College of Cardiology	1996	134
9389420	3569	Pickup JC	NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.	Diabetologia	1997	150
9398739	3569	Mohamed-Ali V	Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.	The Journal of clinical endocrinology and metabolism	1997	276
10720054	3569	Vgontzas AN	Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.	The Journal of clinical endocrinology and metabolism	2000	180
11022058	3569	Vila N	Proinflammatory cytokines and early neurological worsening in ischemic stroke.	Stroke	2000	103
11287357	3569	Kern PA	Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2001	280
11319194	3569	Deswal A	Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).	Circulation	2001	120
11924650	3569	Burke JG	Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators.	The Journal of bone and joint surgery. British volume	2002	109
11983728	3569	Visser M	Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study.	The journals of gerontology. Series A, Biological sciences and medical sciences	2002	178
12379575	3569	Esposito K	Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.	Circulation	2002	268
12480034	3569	Miller GE	Clinical depression and inflammatory risk markers for coronary heart disease.	The American journal of cardiology	2002	93
12626436	3569	Starkie R	Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.	FASEB journal 	2003	96
12857678	3569	Steensberg A	IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.	American journal of physiology. Endocrinology and metabolism	2003	107
12883485	3569	Kugelmas M	Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.	Hepatology	2003	82
14567964	3569	Raper SE	Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.	Molecular genetics and metabolism	2003	272
15126529	3569	Vgontzas AN	Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines.	The Journal of clinical endocrinology and metabolism	2004	197
15150588	3569	Michalaki V	Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer.	British journal of cancer	2004	73
15196211	3569	Schaefer TM	Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.	Immunology	2004	75
15229336	3569	Vendrell J	Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.	Obesity research	2004	78
15356039	3569	Vgontzas AN	Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist.	The Journal of clinical endocrinology and metabolism	2004	79
15780075	3569	Stenvinkel P	IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.	Kidney international	2005	107
16012934	3569	Hart AL	Characteristics of intestinal dendritic cells in inflammatory bowel diseases.	Gastroenterology	2005	95
16052591	3569	Roelofs MF	The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.	Arthritis and rheumatism	2005	72
16613757	3569	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	383
16849509	3569	Levy O	The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.	Journal of immunology	2006	71
16864705	3569	Angelone DF	Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.	Pediatric research	2006	61
16870554	3569	Lu LL	Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.	Haematologica	2006	121
17085599	3569	Sato A	Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17170049	3569	de Jager W	Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.	Annals of the rheumatic diseases	2007	62
17446340	3569	Törnqvist H	Persistent endothelial dysfunction in humans after diesel exhaust inhalation.	American journal of respiratory and critical care medicine	2007	94
17569118	3569	Tedelind S	Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.	World journal of gastroenterology	2007	62
17698689	3569	Kellum JA	Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.	Archives of internal medicine	2007	172
18482990	3569	Cambi A	Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.	The Journal of biological chemistry	2008	52
18753925	3569	Strategies for Management of Anti-Retroviral Therapy/INSIGHT.	Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.	AIDS	2008	81
18771602	3569	Kauer-Sant'Anna M	Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.	The international journal of neuropsychopharmacology	2009	49
19137011	3569	Lin L	The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.	Oncogene	2009	67
19433247	3569	Ben-Jonathan N	Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome.	Molecular and cellular endocrinology	2009	57
19497986	3569	Lehrke M	Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.	European journal of endocrinology	2009	48
19500472	3569	Chang YS	Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.	Cell transplantation	2009	50
19581928	3569	Sullivan NJ	Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.	Oncogene	2009	166
19585655	3569	Marra F	Adipokines in liver diseases.	Hepatology	2009	93
19622783	3569	Gustafson B	Inflammation and impaired adipogenesis in hypertrophic obesity in man.	American journal of physiology. Endocrinology and metabolism	2009	63
19678756	3569	Rodger AJ	Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.	The Journal of infectious diseases	2009	63
19828697	3569	Funderburg NT	Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.	Blood	2010	89
19833726	3569	Roca H	CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization.	The Journal of biological chemistry	2009	128
20032961	3569	Murugan R	Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival.	Kidney international	2010	66
20043983	3569	Eisenberger NI	Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood.	Brain, behavior, and immunity	2010	78
20215499	3569	Germano G	Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.	Cancer research	2010	52
20303729	3569	Laugerette F	Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation.	The Journal of nutritional biochemistry	2011	46
20353817	3569	Wang XS	Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.	Brain, behavior, and immunity	2010	49
20644113	3569	Song SN	Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.	Blood	2010	41
20660122	3569	Roberts ET	Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up.	American journal of epidemiology	2010	81
20664016	3569	Brown TT	Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.	Diabetes care	2010	60
20679216	3569	Slavich GM	Neural sensitivity to social rejection is associated with inflammatory responses to social stress.	Proceedings of the National Academy of Sciences of the United States of America	2010	78
20816981	3569	Stannus O	Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults.	Osteoarthritis and cartilage	2010	45
21220315	3569	Iliopoulos D	Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.	Proceedings of the National Academy of Sciences of the United States of America	2011	170
21408027	3569	Bao B	Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.	PloS one	2011	71
21414532	3569	Silvain J	Composition of coronary thrombus in acute myocardial infarction.	Journal of the American College of Cardiology	2011	43
21519361	3569	Begue B	Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.	The American journal of gastroenterology	2011	40
21726511	3569	Sandler NG	Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.	Gastroenterology	2011	90
21801431	3569	Chen DY	Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.	Arthritis research and therapy	2011	36
21809006	3569	Niu Q	Disturbed Th17/Treg balance in patients with rheumatoid arthritis.	Rheumatology international	2012	33
22035595	3569	Mirza S	Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study.	Cytokine	2012	35
22426431	3569	Coussons-Read ME	The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation.	Brain, behavior, and immunity	2012	40
22527592	3569	Illán-Gómez F	Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery.	Obesity surgery	2012	31
22692596	3569	Endo S	Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.	Journal of infection and chemotherapy 	2012	40
22698992	3569	Kesler S	Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors.	Brain, behavior, and immunity	2013	54
22743373	3569	Ostrowski SR	Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.	The journal of trauma and acute care surgery	2012	36
23065151	3569	Funderburg NT	Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.	Blood	2012	73
23071313	3569	Rossato M	IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
23159929	3569	Ghosh A	Telomerase directly regulates NF-κB-dependent transcription.	Nature cell biology	2012	60
23349310	3569	Melief SM	Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.	Haematologica	2013	29
23486877	3569	Desplats P	Molecular and pathologic insights from latent HIV-1 infection in the human brain.	Neurology	2013	53
23536012	3569	Khandpur R	NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.	Science translational medicine	2013	153
23559466	3569	Erlandson KM	Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.	The Journal of infectious diseases	2013	46
24117923	3569	Xiao S	A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.	FEMS microbiology ecology	2014	36
24370923	3569	Daniele G	The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.	Acta diabetologica	2014	21
24828436	3569	Bala S	Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.	PloS one	2014	38
25387317	3569	Somsouk M	Gut epithelial barrier and systemic inflammation during chronic HIV infection.	AIDS	2015	26
25583168	3569	Hileman CO	Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.	The Journal of infectious diseases	2015	16
25731872	3569	Dubuquoy L	Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.	Gut	2015	15
25787249	3569	Puthanveetil P	Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.	Journal of cellular and molecular medicine	2015	18
26858430	3569	Morris CJ	Circadian misalignment increases cardiovascular disease risk factors in humans.	Proceedings of the National Academy of Sciences of the United States of America	2016	16
10606205	4072	Balzar M	The biology of the 17-1A antigen (Ep-CAM).	Journal of molecular medicine	1999	111
14745734	4072	Went PT	Frequent EpCam protein expression in human carcinomas.	Human pathology	2004	157
15195135	4072	Münz M	The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.	Oncogene	2004	81
15942643	4072	Rao CG	Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.	International journal of oncology	2005	86
16404366	4072	Went P	Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.	British journal of cancer	2006	85
19098912	4072	Ligtenberg MJ	Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.	Nature genetics	2009	137
19136966	4072	Maetzel D	Nuclear signalling by tumour-associated antigen EpCAM.	Nature cell biology	2009	194
19584271	4072	Munz M	The emerging role of EpCAM in cancer and stem cell signaling.	Cancer research	2009	131
19585654	4072	Ji J	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.	Hepatology	2009	145
20064925	4072	Lu TY	Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells.	The Journal of biological chemistry	2010	44
20147742	4072	Coumans FA	All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.	Annals of oncology 	2010	60
20190561	4072	Linke R	Catumaxomab: clinical development and future directions.	mAbs	2010	46
20347527	4072	Seimetz D	Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.	Cancer treatment reviews	2010	44
20837599	4072	van der Gun BT	EpCAM in carcinogenesis: the good, the bad or the ugly.	Carcinogenesis	2010	85
21261508	4072	Königsberg R	Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.	Acta oncologica	2011	58
21281402	4072	Shigdar S	RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.	Cancer science	2011	36
21319194	4072	Yoon SM	Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans.	Hepatology	2011	41
21415054	4072	Spizzo G	EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.	Journal of clinical pathology	2011	42
21576002	4072	Patriarca C	Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.	Cancer treatment reviews	2012	60
21601258	4072	Rupp AK	Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.	Gynecologic oncology	2011	42
21829190	4072	Farace F	A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas.	British journal of cancer	2011	90
22825490	4072	Saucedo-Zeni N	A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.	International journal of oncology	2012	54
23230278	4072	Tauro BJ	Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.	Molecular and cellular proteomics 	2013	62
23480100	4072	Song Y	Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.	Analytical chemistry	2013	30
23486470	4072	Wu CJ	Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.	The Journal of biological chemistry	2013	28
23616258	4072	Schulze K	Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.	International journal of cancer	2013	31
24061411	4072	Sollier E	Size-selective collection of circulating tumor cells using Vortex technology.	Lab on a chip	2014	47
24141784	4072	Driemel C	Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.	Oncogene	2014	21
25336717	4072	Satelli A	Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.	Clinical chemistry	2015	28
26184843	4072	de Wit S	The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.	Scientific reports	2015	24
12674330	4162	Shi S	Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.	Journal of bone and mineral research 	2003	259
17332507	4162	Baksh D	Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow.	Stem cells	2007	191
17872908	4162	Schwab KE	Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium.	Human reproduction	2007	94
21415267	4162	Tormin A	CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.	Blood	2011	86
21861688	4162	Corselli M	The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells.	Stem cells and development	2012	81
22282356	4162	Mund JA	Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells.	Arteriosclerosis, thrombosis, and vascular biology	2012	32
23600480	4162	Blocki A	Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis.	Stem cells and development	2013	36
18154452	4363	Sharom FJ	ABC multidrug transporters: structure, function and role in chemoresistance.	Pharmacogenomics	2008	152
19711346	4363	Zhu Z	Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.	International journal of cancer	2010	99
21900104	4363	Visscher H	Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.	Journal of clinical oncology 	2012	54
9539782	4582	Racila E	Detection and characterization of carcinoma cells in the blood.	Proceedings of the National Academy of Sciences of the United States of America	1998	111
14998492	4582	Ren J	Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.	Cancer cell	2004	108
15710329	4582	Wei X	Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.	Cancer cell	2005	74
17090543	4582	Yu LG	Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.	The Journal of biological chemistry	2007	79
17889671	4582	Ramasamy S	The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.	Molecular cell	2007	76
17898272	4582	Blalock TD	Functions of MUC16 in corneal epithelial cells.	Investigative ophthalmology and visual science	2007	67
17988798	4582	Tarp MA	Mucin-type O-glycosylation and its potential use in drug and vaccine development.	Biochimica et biophysica acta	2008	67
18931053	4582	Kesimer M	Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?	American journal of physiology. Lung cellular and molecular physiology	2009	54
19190083	4582	Kesimer M	Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense.	FASEB journal 	2009	70
19377061	4582	Yue T	The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays.	Molecular and cellular proteomics 	2009	48
19491255	4582	Raina D	Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.	Cancer research	2009	65
19706766	4582	Ahmad R	MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.	Cancer research	2009	68
19816567	4582	Lindén SK	MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.	PLoS pathogens	2009	60
20124478	4582	Wandall HH	Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.	Cancer research	2010	69
21421804	4582	Raina D	Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.	Molecular cancer therapeutics	2011	55
22019520	4582	Quoix E	Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.	The Lancet. Oncology	2011	68
23248097	4582	Kimura T	MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.	Cancer prevention research	2013	46
23446997	4582	Remmers N	Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.	Clinical cancer research 	2013	37
23484797	4582	Dawson SJ	Analysis of circulating tumor DNA to monitor metastatic breast cancer.	The New England journal of medicine	2013	320
24331154	4582	Butts C	Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.	The Lancet. Oncology	2014	67
24384091	4582	Gnemmi V	MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.	Cancer letters	2014	22
24781336	4582	Zhai X	Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.	Medical oncology	2014	27
9005853	4653	Stone EM	Identification of a gene that causes primary open angle glaucoma.	Science	1997	327
10196380	4653	Fingert JH	Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.	Human molecular genetics	1999	134
19554483	4653	Tomarev SI	Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.	Molecular neurobiology	2009	45
21562585	4653	Fingert JH	Primary open-angle glaucoma genes.	Eye	2011	58
6868370	4758	Rogers GN	Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.	Virology	1983	210
9065404	4758	Taubenberger JK	Initial genetic characterization of the 1918 "Spanish" influenza virus.	Science	1997	124
9882316	4758	Matrosovich M	The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.	Journal of virology	1999	173
15470432	4758	Kobasa D	Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.	Nature	2004	139
15659762	4758	Puthavathana P	Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.	The Journal of general virology	2005	66
15744059	4758	Suzuki Y	Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses.	Biological and pharmaceutical bulletin	2005	68
16228009	4758	Le QM	Avian flu: isolation of drug-resistant H5N1 virus.	Nature	2005	196
16282492	4758	Tumpey TM	Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.	Journal of virology	2005	168
16318689	4758	World Health Organization Global Influenza Program Surveillance Network.	Evolution of H5N1 avian influenza viruses in Asia.	Emerging infectious diseases	2005	126
16420364	4758	King SJ	Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae.	Molecular microbiology	2006	82
16533883	4758	Salomon R	The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.	The Journal of experimental medicine	2006	152
16945980	4758	Chen R	Avian influenza virus exhibits rapid evolutionary dynamics.	Molecular biology and evolution	2006	67
17146053	4758	Harris A	Influenza virus pleiomorphy characterized by cryoelectron tomography.	Proceedings of the National Academy of Sciences of the United States of America	2006	129
17855542	4758	Yen HL	Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.	Journal of virology	2007	67
17942961	4758	Singh A	Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.	Journal of the American Society of Nephrology 	2007	60
19211790	4758	Van Hoeven N	Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air.	Proceedings of the National Academy of Sciences of the United States of America	2009	94
21390205	4758	Kryazhimskiy S	Prevalence of epistasis in the evolution of influenza A surface proteins.	PLoS genetics	2011	65
21825167	4758	Yen HL	Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets.	Proceedings of the National Academy of Sciences of the United States of America	2011	72
21878571	4758	Palese P	Why do influenza virus subtypes die out? A hypothesis.	mBio	2011	45
22308500	4758	Pica N	Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.	Proceedings of the National Academy of Sciences of the United States of America	2012	90
22718832	4758	Xu R	Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic.	Journal of virology	2012	58
23307936	4758	Couch RB	Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.	The Journal of infectious diseases	2013	39
23641061	4758	Zhang Y	H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet.	Science	2013	62
24261589	4758	Cohen M	Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.	Virology journal	2013	32
24371052	4758	Westgeest KB	Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011.	Journal of virology	2014	25
24429367	4758	Campbell PJ	The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.	Journal of virology	2014	24
24453375	4758	Krammer F	Divergent H7 immunogens offer protection from H7N9 virus challenge.	Journal of virology	2014	23
24891213	4758	Webster RG	Continuing challenges in influenza.	Annals of the New York Academy of Sciences	2014	41
24960271	4758	Wohlbold TJ	In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.	Viruses	2014	23
11917100	5175	Levenberg S	Endothelial cells derived from human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	147
14500637	5175	Potian JA	Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens.	Journal of immunology	2003	94
15126324	5175	Uzzan B	Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.	Cancer research	2004	94
15635089	5175	Boquest AC	Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture.	Molecular biology of the cell	2005	76
16773076	5175	Des Guetz G	Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.	British journal of cancer	2006	78
17460736	5175	Gazzaniga S	Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.	The Journal of investigative dermatology	2007	66
18583570	5175	Kohler S	Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets.	Blood	2009	68
18652940	5175	Joner M	Endothelial cell recovery between comparator polymer-based drug-eluting stents.	Journal of the American College of Cardiology	2008	76
19259936	5175	Choi KD	Hematopoietic and endothelial differentiation of human induced pluripotent stem cells.	Stem cells	2009	135
20496415	5175	Christopher-Stine L	A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.	Arthritis and rheumatism	2010	51
20979453	5175	Wightman F	Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.	The Journal of infectious diseases	2010	41
24412187	5175	Beer AJ	PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.	JACC. Cardiovascular imaging	2014	24
24467430	5175	Manetti M	A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis.	Journal of cellular and molecular medicine	2014	24
25418725	5175	Lian X	Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling.	Stem cell reports	2014	38
1360704	5243	Cole SP	Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.	Science	1992	341
2444983	5243	Thiebaut F	Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.	Proceedings of the National Academy of Sciences of the United States of America	1987	302
2563168	5243	Cordon-Cardo C	Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.	Proceedings of the National Academy of Sciences of the United States of America	1989	193
2876781	5243	Chen CJ	Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.	Cell	1986	250
8898203	5243	van Helvoort A	MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.	Cell	1996	117
10716719	5243	Hoffmeyer S	Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2000	268
11503014	5243	Kim RB	Identification of functionally variant MDR1 alleles among European Americans and African Americans.	Clinical pharmacology and therapeutics	2001	105
14576852	5243	Ambudkar SV	P-glycoprotein: from genomics to mechanism.	Oncogene	2003	159
14749689	5243	Marzolini C	Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.	Clinical pharmacology and therapeutics	2004	109
15324696	5243	Szakács G	Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.	Cancer cell	2004	113
15668963	5243	Kortekaas R	Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.	Annals of neurology	2005	104
17015488	5243	Sarkadi B	Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.	Physiological reviews	2006	134
17942888	5243	Sauna ZE	Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.	Cancer research	2007	60
17947497	5243	Shen F	Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.	The Journal of pharmacology and experimental therapeutics	2008	53
18441325	5243	Bourguignon LY	Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.	The Journal of biological chemistry	2008	109
18577180	5243	Dunkel N	Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.	Molecular microbiology	2008	77
18829547	5243	Dai CL	Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.	Cancer research	2008	90
19349543	5243	Lara PN Jr	Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.	Journal of clinical oncology 	2009	82
19383919	5243	Dong X	Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.	Cancer research	2009	50
19819701	5243	Gutmann DA	Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1.	Trends in biochemical sciences	2010	48
20388796	5243	Yoo BK	Molecular mechanism of chemoresistance by astrocyte elevated gene-1.	Cancer research	2010	45
20731437	5243	Meng H	Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.	ACS nano	2010	95
21627074	5243	Xiong XB	Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin.	ACS nano	2011	52
21967057	5243	Sharom FJ	The P-glycoprotein multidrug transporter.	Essays in biochemistry	2011	64
22120145	5243	van Assema DM	Blood-brain barrier P-glycoprotein function in Alzheimer's disease.	Brain 	2012	42
22344233	5243	Chen KG	Molecular pathways: regulation and therapeutic implications of multidrug resistance.	Clinical cancer research 	2012	34
22409994	5243	Shaffer BC	Drug resistance: still a daunting challenge to the successful treatment of AML.	Drug resistance updates 	2012	36
22703054	5243	Prasad R	Yeast ATP-binding cassette transporters conferring multidrug resistance.	Annual review of microbiology	2012	45
23721823	5243	Januchowski R	The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.	Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie	2013	27
24311721	5243	Laszlo GS	Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.	Blood	2014	25
24395888	5243	Ramesh R	Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.	The Journal of experimental medicine	2014	72
24958102	5243	Wang Y	Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.	Molecular and cellular biology	2014	23
2785681	5265	Newton CR	Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).	Nucleic acids research	1989	347
16183649	5265	Hidvegi T	Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response.	The Journal of biological chemistry	2005	66
19706466	5265	Brantly ML	Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.	Proceedings of the National Academy of Sciences of the United States of America	2009	120
20522742	5265	Hidvegi T	An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.	Science	2010	157
21459797	5265	Yang N	Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.	Clinical cancer research 	2011	39
21609134	5265	Flotte TR	Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.	Human gene therapy	2011	81
21960536	5265	Stoller JK	A review of α1-antitrypsin deficiency.	American journal of respiratory and critical care medicine	2012	43
21993621	5265	Yusa K	Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.	Nature	2011	170
22808956	5265	Lyons PA	Genetically distinct subsets within ANCA-associated vasculitis.	The New England journal of medicine	2012	94
24476432	5806	Cunha C	Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.	The New England journal of medicine	2014	45
8099202	5979	Mulligan LM	Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.	Nature	1993	182
12000816	5979	Neumann HP	Germ-line mutations in nonsyndromic pheochromocytoma.	The New England journal of medicine	2002	169
12670889	5979	Kimura ET	High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.	Cancer research	2003	259
12881714	5979	Soares P	BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.	Oncogene	2003	101
15769183	5979	Cerchia L	Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase.	PLoS biology	2005	67
15829955	5979	Emison ES	A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk.	Nature	2005	124
15982921	5979	Arighi E	RET tyrosine kinase signaling in development and cancer.	Cytokine and growth factor reviews	2005	69
16314641	5979	Amar L	Genetic testing in pheochromocytoma or functional paraganglioma.	Journal of clinical oncology 	2005	92
18073307	5979	Elisei R	Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.	The Journal of clinical endocrinology and metabolism	2008	56
20598273	5979	Emison ES	Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability.	American journal of human genetics	2010	55
22327624	5979	Kohno T	KIF5B-RET fusions in lung adenocarcinoma.	Nature medicine	2012	170
23150706	5979	Wang R	RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.	Journal of clinical oncology 	2012	77
15479743	6382	Beauvais DM	The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.	The Journal of cell biology	2004	83
16634029	6382	Stüve O	Immune surveillance in multiple sclerosis patients treated with natalizumab.	Annals of neurology	2006	94
17097330	6382	Alexopoulou AN	Syndecans in wound healing, inflammation and vascular biology.	The international journal of biochemistry and cell biology	2007	86
17347152	6382	Yang Y	Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.	The Journal of biological chemistry	2007	96
19126645	6382	Nikolova V	Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.	Carcinogenesis	2009	46
19423849	6382	Chappell D	The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture.	Circulation research	2009	45
20081059	6382	Caraux A	Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.	Haematologica	2010	46
21257720	6382	Ritchie JP	SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.	Clinical cancer research 	2011	55
21772125	6382	Johansson PI	A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients.	Annals of surgery	2011	61
1689464	6401	Geng JG	Rapid neutrophil adhesion to activated endothelium mediated by GMP-140.	Nature	1990	169
2466335	6401	Bevilacqua MP	Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.	Science	1989	347
17991637	6401	Erridge C	A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation.	The American journal of clinical nutrition	2007	133
18165643	6401	Garcia AA	Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.	Journal of clinical oncology 	2008	129
18794336	6401	Clark RA	Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.	The Journal of experimental medicine	2008	57
20452433	6401	Läubli H	Selectins promote tumor metastasis.	Seminars in cancer biology	2010	73
22344286	6401	Hughes AD	Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.	Clinical chemistry	2012	35
22771675	6401	Eirin A	Inflammatory and injury signals released from the post-stenotic human kidney.	European heart journal	2013	35
24602331	6401	Zonneveld R	Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults.	Critical care	2014	22
2472431	6403	McEver RP	GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.	The Journal of clinical investigation	1989	162
7532174	6403	Moore KL	P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.	The Journal of cell biology	1995	155
8968075	6403	Hakomori S	Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.	Cancer research	1996	160
11081633	6403	Somers WS	Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.	Cell	2000	143
3399080	6531	McGeer PL	Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.	Neurology	1988	417
9126740	6531	Volkow ND	Relationship between subjective effects of cocaine and dopamine transporter occupancy.	Nature	1997	130
9417971	6531	Gunn RN	Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.	NeuroImage	1997	167
9537821	6531	Tatsumi M	Pharmacological profile of antidepressants and related compounds at human monoamine transporters.	European journal of pharmacology	1997	121
9763484	6531	McCann UD	Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with 11CWIN-35,428.	The Journal of neuroscience 	1998	123
9766762	6531	Volkow ND	Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.	The American journal of psychiatry	1998	112
10649826	6531	Heinz A	Genotype influences in vivo dopamine transporter availability in human striatum.	Neuropsychopharmacology 	2000	116
10823899	6531	Saunders C	Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2000	99
11160455	6531	Volkow ND	Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.	The Journal of neuroscience 	2001	104
11229977	6531	Volkow ND	Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.	The American journal of psychiatry	2001	223
11292651	6531	Lee FJ	Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.	FASEB journal 	2001	88
11911442	6531	Fuke S	The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.	The pharmacogenomics journal	2001	90
15590952	6531	Fahn S	Levodopa and the progression of Parkinson's disease.	The New England journal of medicine	2004	180
15872345	6531	van Dyck CH	Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.	Journal of nuclear medicine 	2005	80
8632190	6532	Heils A	Allelic variation of human serotonin transporter gene expression.	Journal of neurochemistry	1996	376
8929413	6532	Lesch KP	Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.	Science	1996	867
11602621	6532	Eddahibi S	Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.	The Journal of clinical investigation	2001	100
11803458	6532	Bennett AJ	Early experience and serotonin transporter gene variation interact to influence primate CNS function.	Molecular psychiatry	2002	135
12130784	6532	Hariri AR	Serotonin transporter genetic variation and the response of the human amygdala.	Science	2002	485
12869766	6532	Caspi A	Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.	Science	2003	1436
12973026	6532	Ichise M	Linearized reference tissue parametric imaging methods: application to 11CDASB positron emission tomography studies of the serotonin transporter in human brain.	Journal of cerebral blood flow and metabolism 	2003	143
15188158	6532	Coates MD	Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.	Gastroenterology	2004	161
15563601	6532	Kaufman J	Social supports and serotonin transporter gene moderate depression in maltreated children.	Proceedings of the National Academy of Sciences of the United States of America	2004	187
15592465	6532	Heinz A	Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter.	Nature neuroscience	2005	164
15635638	6532	Feinn R	Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	74
15699291	6532	Hariri AR	A susceptibility gene for affective disorders and the response of the human amygdala.	Archives of general psychiatry	2005	217
15867106	6532	Kendler KS	The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication.	Archives of general psychiatry	2005	165
15880108	6532	Pezawas L	5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.	Nature neuroscience	2005	483
11162539	6696	Fisher LW	Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin.	Biochemical and biophysical research communications	2001	139
11929952	6696	Agrawal D	Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.	Journal of the National Cancer Institute	2002	82
12640447	6696	Ye QH	Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.	Nature medicine	2003	183
12952171	6696	Fisher LW	Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins.	Connective tissue research	2003	112
14734468	6696	Coppola D	Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.	Clinical cancer research 	2004	72
15138464	6696	Rittling SR	Role of osteopontin in tumour progression.	British journal of cancer	2004	96
15501463	6696	Wai PY	The role of Osteopontin in tumor metastasis.	The Journal of surgical research	2004	74
15896949	6696	Nuttelman CR	Synthetic hydrogel niches that promote hMSC viability.	Matrix biology 	2005	83
16221779	6696	Pass HI	Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.	The New England journal of medicine	2005	76
17910028	6696	Kazanecki CC	Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.	Journal of cellular biochemistry	2007	66
18555776	6696	McAllister SS	Systemic endocrine instigation of indolent tumor growth requires osteopontin.	Cell	2008	131
19444308	6696	Steinman L	A molecular trio in relapse and remission in multiple sclerosis.	Nature reviews. Immunology	2009	50
20597997	6696	Anborgh PH	Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.	Journal of cellular and molecular medicine	2010	46
20823889	6696	Weber GF	Osteopontin is a marker for cancer aggressiveness and patient survival.	British journal of cancer	2010	49
21178099	6696	Pegoraro E	SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.	Neurology	2011	63
21826088	6696	Altamirano J	Alcoholic liver disease: pathogenesis and new targets for therapy.	Nature reviews. Gastroenterology and hepatology	2011	55
21953299	6696	Shang S	Identification of osteopontin as a novel marker for early hepatocellular carcinoma.	Hepatology	2012	67
23729174	6696	Morales-Ibanez O	Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.	Hepatology	2013	32
25476005	6696	van den Bergen JC	Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.	Journal of neurology, neurosurgery, and psychiatry	2015	17
25641372	6696	Bello L	Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.	Annals of neurology	2015	20
18801935	7038	Hoofnagle AN	Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.	Clinical chemistry	2008	76
19773371	7038	Hoftijzer H	Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.	European journal of endocrinology	2009	47
24434360	7038	Caturegli P	Hashimoto thyroiditis: clinical and diagnostic criteria.	Autoimmunity reviews	2014	35
9751057	7097	Yang RB	Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.	Nature	1998	195
10384090	7097	Yoshimura A	Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.	Journal of immunology	1999	258
10426996	7097	Aliprantis AO	Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.	Science	1999	351
10452971	7097	Hirschfeld M	Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.	Journal of immunology	1999	164
10559223	7097	Lien E	Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.	The Journal of biological chemistry	1999	227
11035751	7097	Lorenz E	A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.	Infection and immunity	2000	101
11083826	7097	Cario E	Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.	Infection and immunity	2000	240
11101877	7097	Arbibe L	Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.	Nature immunology	2000	174
11477091	7097	Re F	Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.	The Journal of biological chemistry	2001	136
11836257	7097	Asea A	Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.	The Journal of biological chemistry	2002	307
11842086	7097	Vabulas RM	HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.	The Journal of biological chemistry	2002	197
12430718	7097	Bsibsi M	Broad expression of Toll-like receptors in the human central nervous system.	Journal of neuropathology and experimental neurology	2002	216
12538701	7097	Melmed G	Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.	Journal of immunology	2003	111
12663765	7097	Compton T	Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.	Journal of virology	2003	181
12946842	7097	Becker I	Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.	Molecular and biochemical parasitology	2003	90
14607814	7097	Adamo R	Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5.	American journal of respiratory cell and molecular biology	2004	77
14979495	7097	Ogus AC	The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease.	The European respiratory journal	2004	90
14981245	7097	Komai-Koma M	TLR2 is expressed on activated T cells as a costimulatory receptor.	Proceedings of the National Academy of Sciences of the United States of America	2004	119
15007351	7097	Eder W	Toll-like receptor 2 as a major gene for asthma in children of European farmers.	The Journal of allergy and clinical immunology	2004	88
15294983	7097	Gehring AJ	Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.	Journal of immunology	2004	75
15521019	7097	Dolganiuc A	Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.	Gastroenterology	2004	98
16011525	7097	Furrie E	Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.	Immunology	2005	68
16878026	7097	Yu M	HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.	Shock	2006	220
17082626	7097	Boehme KW	Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells.	Journal of immunology	2006	102
18029454	7097	Devaraj S	Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.	The Journal of clinical endocrinology and metabolism	2008	93
18458151	7097	Nilsen NJ	Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.	Journal of leukocyte biology	2008	50
19509287	7097	Benakanakere MR	Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes.	The Journal of biological chemistry	2009	48
19735274	7097	Sjögren YM	Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses.	Clinical and experimental allergy 	2009	63
21248167	7097	Jiang D	Hyaluronan as an immune regulator in human diseases.	Physiological reviews	2011	162
22496225	7097	Leoni V	Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κB.	Journal of virology	2012	41
2158863	7124	Schall TJ	Molecular cloning and expression of a receptor for human tumor necrosis factor.	Cell	1990	149
2657427	7124	Grau GE	Tumor necrosis factor and disease severity in children with falciparum malaria.	The New England journal of medicine	1989	211
2762307	7124	Duh EJ	Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.	Proceedings of the National Academy of Sciences of the United States of America	1989	228
2880163	7124	Waage A	Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.	Lancet	1987	172
7797011	7124	van Dullemen HM	Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).	Gastroenterology	1995	134
7935762	7124	McGuire W	Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.	Nature	1994	149
8015728	7124	Mogi M	Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.	Neuroscience letters	1994	133
8198398	7124	Tracey KJ	Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.	Annual review of medicine	1994	148
9321530	7124	Targan SR	A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.	The New England journal of medicine	1997	358
9435233	7124	Grell M	The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.	Proceedings of the National Academy of Sciences of the United States of America	1998	101
9725266	7124	Balcewicz-Sablinska MK	Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.	Journal of immunology	1998	106
10449104	7124	-	TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.	Neurology	1999	134
10604883	7124	Ouchi N	Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.	Circulation	1999	304
10622295	7124	Maini R	Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.	Lancet	1999	332
10801754	7124	Ridker PM	Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.	Circulation	2000	139
11096166	7124	Lipsky PE	Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.	The New England journal of medicine	2000	455
11156641	7124	Wigg AJ	The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.	Gut	2001	123
11596589	7124	Keane J	Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.	The New England journal of medicine	2001	504
11732005	7124	Crespo J	Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.	Hepatology	2001	115
11762947	7124	Mohan N	Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.	Arthritis and rheumatism	2001	96
11792859	7124	Angelini G	Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.	Proceedings of the National Academy of Sciences of the United States of America	2002	83
11828008	7124	Piccioli D	Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.	The Journal of experimental medicine	2002	146
11907116	7124	Belge KU	The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.	Journal of immunology	2002	167
11961039	7124	Scallon B	Binding and functional comparisons of two types of tumor necrosis factor antagonists.	The Journal of pharmacology and experimental therapeutics	2002	95
12086951	7124	Kirwan JP	TNF-alpha is a predictor of insulin resistance in human pregnancy.	Diabetes	2002	91
12493553	7124	Panossian LA	Telomere shortening in T cells correlates with Alzheimer's disease status.	Neurobiology of aging	2003	94
12528101	7124	Weinblatt ME	Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.	Arthritis and rheumatism	2003	249
12584368	7124	Baert F	Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.	The New England journal of medicine	2003	224
12672326	7124	Baughman RP	Sarcoidosis.	Lancet	2003	76
12799470	7124	Borisy AA	Systematic discovery of multicomponent therapeutics.	Proceedings of the National Academy of Sciences of the United States of America	2003	140
12829646	7124	Kern PA	Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.	Diabetes	2003	143
12905464	7124	Gómez-Reino JJ	Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.	Arthritis and rheumatism	2003	128
12949498	7124	Aggarwal BB	Signalling pathways of the TNF superfamily: a double-edged sword.	Nature reviews. Immunology	2003	502
14555214	7124	Gaur U	Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.	Biochemical pharmacology	2003	101
14719195	7124	Furst DE	Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).	The Journal of rheumatology	2003	78
14988838	7124	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	127
15044327	7124	Hagemann T	Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.	Carcinogenesis	2004	92
15127338	7124	Wallis RS	Granulomatous infectious diseases associated with tumor necrosis factor antagonists.	Clinical infectious diseases 	2004	122
15146409	7124	Keystone EC	Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.	Arthritis and rheumatism	2004	209
15208584	7124	Wright RJ	Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy.	The Journal of allergy and clinical immunology	2004	71
15383371	7124	Tchkonia T	Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.	American journal of physiology. Endocrinology and metabolism	2005	67
15383597	7124	Levy O	Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.	Journal of immunology	2004	99
15613320	7124	Yonezawa A	Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.	Journal of virology	2005	70
15626980	7124	Weiler C	Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls.	Spine	2005	82
15641080	7124	Kobayashi M	Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.	Arthritis and rheumatism	2005	89
15728381	7124	Palucka AK	Cross-regulation of TNF and IFN-alpha in autoimmune diseases.	Proceedings of the National Academy of Sciences of the United States of America	2005	99
16151404	7124	Hoogenboom HR	Selecting and screening recombinant antibody libraries.	Nature biotechnology	2005	185
16162882	7124	Genovese MC	Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.	The New England journal of medicine	2005	212
16200601	7124	Mease PJ	Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.	Arthritis and rheumatism	2005	96
16226614	7124	Reich K	Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.	Lancet	2005	102
16439435	7124	Schiff MH	Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.	Annals of the rheumatic diseases	2006	60
16447241	7124	Wolfe F	Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.	Arthritis and rheumatism	2006	60
16472588	7124	Hanauer SB	Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.	Gastroenterology	2006	192
16481637	7124	Berry MA	Evidence of a role of tumor necrosis factor alpha in refractory asthma.	The New England journal of medicine	2006	150
16573591	7124	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	96
16705046	7124	Hyrich KL	Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Rheumatology	2006	103
16705109	7124	Bongartz T	Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.	JAMA	2006	366
16798876	7124	Yang H	TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16802350	7124	van der Heijde D	Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.	Arthritis and rheumatism	2006	102
16804108	7124	Casals-Pascual C	Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo.	Blood	2006	61
16868999	7124	Dixon WG	Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.	Arthritis and rheumatism	2006	87
16971520	7124	McCoy MK	Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.	The Journal of neuroscience 	2006	98
17093155	7124	Weiss EP	Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial.	The American journal of clinical nutrition	2006	106
17195186	7124	Hyrich KL	Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.	Arthritis and rheumatism	2007	67
17202130	7124	Popa C	The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.	Journal of lipid research	2007	83
17339326	7124	Hamik A	Kruppel-like factor 4 regulates endothelial inflammation.	The Journal of biological chemistry	2007	115
17393394	7124	Curtis JR	Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.	Arthritis and rheumatism	2007	56
17469100	7124	Wolfe F	The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.	Arthritis and rheumatism	2007	57
17470824	7124	Sandborn WJ	Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.	Annals of internal medicine	2007	104
17560496	7124	Chez MG	Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.	Pediatric neurology	2007	65
17632266	7124	Ramos-Casals M	Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.	Medicine	2007	73
17660390	7124	Rajesh M	CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.	American journal of physiology. Heart and circulatory physiology	2007	70
17702576	7124	Zhu G	Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.	Current biology 	2007	70
17763428	7124	Dixon WG	Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.	Arthritis and rheumatism	2007	69
17916444	7124	Wong M	TNFalpha blockade in human diseases: mechanisms and future directions.	Clinical immunology	2008	64
18036647	7124	Brightling C	Targeting TNF-alpha: a novel therapeutic approach for asthma.	The Journal of allergy and clinical immunology	2008	63
18048652	7124	Vasudevan S	Switching from repression to activation: microRNAs can up-regulate translation.	Science	2007	784
18161752	7124	Bradley JR	TNF-mediated inflammatory disease.	The Journal of pathology	2008	251
18184433	7124	Tobinick EL	Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.	Journal of neuroinflammation	2008	53
18438840	7124	Mitoma H	Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.	Arthritis and rheumatism	2008	51
18485876	7124	Wang L	TNF-alpha induces two distinct caspase-8 activation pathways.	Cell	2008	297
18492747	7124	Hivert MF	Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.	The Journal of clinical endocrinology and metabolism	2008	70
18550004	7124	Peyrin-Biroulet L	Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.	Clinical gastroenterology and hepatology 	2008	76
18560012	7124	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	76
18566296	7124	Apovian CM	Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2008	90
18613827	7124	Feldmann M	Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.	Immunological reviews	2008	59
18625622	7124	Emery P	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.	Annals of the rheumatic diseases	2008	181
18632147	7124	Ruperto N	Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.	Lancet	2008	62
18709470	7124	Yang H	Mesothelioma epidemiology, carcinogenesis, and pathogenesis.	Current treatment options in oncology	2008	52
18716298	7124	Lovell DJ	Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.	The New England journal of medicine	2008	71
18848937	7124	Boetticher NC	A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.	Gastroenterology	2008	62
19015206	7124	Fleischmann R	Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.	Annals of the rheumatic diseases	2009	64
19019895	7124	Radstake TR	Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.	Annals of the rheumatic diseases	2009	68
19117595	7124	Furst DE	The risk of infections with biologic therapies for rheumatoid arthritis.	Seminars in arthritis and rheumatism	2010	43
19136369	7124	Wenzel SE	A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.	American journal of respiratory and critical care medicine	2009	68
19168509	7124	Heymans S	Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.	European journal of heart failure	2009	53
19210794	7124	Jones SE	Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.	BMC microbiology	2009	56
19224750	7124	Strangfeld A	Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.	JAMA	2009	79
19249397	7124	Rutgeerts P	Biological therapies for inflammatory bowel diseases.	Gastroenterology	2009	72
19333944	7124	Kavanaugh A	Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.	Arthritis and rheumatism	2009	60
19419979	7124	Aouizerat BE	Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue.	Biological research for nursing	2009	50
19421244	7124	McKellar GE	Role for TNF in atherosclerosis? Lessons from autoimmune disease.	Nature reviews. Cardiology	2009	52
19558997	7124	Siegel CA	Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.	Clinical gastroenterology and hepatology 	2009	66
19560810	7124	Smolen JS	Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.	Lancet	2009	68
19565495	7124	Tubach F	Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.	Arthritis and rheumatism	2009	66
19652016	7124	Smith AM	Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.	The Journal of experimental medicine	2009	107
19689289	7124	Esposito E	TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.	Current medicinal chemistry	2009	45
19738171	7124	Holmes C	Systemic inflammation and disease progression in Alzheimer disease.	Neurology	2009	165
19826084	7124	Wada Y	A wave of nascent transcription on activated human genes.	Proceedings of the National Academy of Sciences of the United States of America	2009	72
19854715	7124	Dixon WG	Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).	Annals of the rheumatic diseases	2010	71
20145610	7124	Afif W	Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease.	The American journal of gastroenterology	2010	70
20173395	7124	Sfikakis PP	The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.	Current directions in autoimmunity	2010	53
20862678	7124	Saevarsdottir S	Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.	Arthritis and rheumatism	2011	39
20876255	7124	Libutti SK	Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.	Clinical cancer research 	2010	91
20888436	7124	Kotlyar DS	A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.	Clinical gastroenterology and hepatology 	2011	46
20957658	7124	Barnabe C	Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.	Arthritis care and research	2011	44
21045814	7124	D'Haens GR	The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?	The American journal of gastroenterology	2011	73
21109516	7124	Greenberg JD	Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.	Annals of the rheumatic diseases	2011	49
21133840	7124	Parameswaran N	Tumor necrosis factor-α signaling in macrophages.	Critical reviews in eukaryotic gene expression	2010	89
21209123	7124	Reinisch W	Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.	Gut	2011	104
21245297	7124	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	50
21254282	7124	Askling J	Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.	Pharmacoepidemiology and drug safety	2011	41
21330639	7124	Soliman MM	Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Annals of the rheumatic diseases	2011	35
21366636	7124	Ben-Horin S	Review article: loss of response to anti-TNF treatments in Crohn's disease.	Alimentary pharmacology and therapeutics	2011	54
21540200	7124	van der Heijde D	2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.	Annals of the rheumatic diseases	2011	55
21569482	7124	Danchuk S	Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6.	Stem cell research and therapy	2011	54
21571731	7124	Chatzidionysiou K	Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.	Annals of the rheumatic diseases	2011	37
21693740	7124	Solomon DH	Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.	JAMA	2011	64
21917936	7124	Yang X	Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.	Investigative ophthalmology and visual science	2011	37
21969554	7124	Rajaram MV	Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
22056398	7124	Grijalva CG	Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.	JAMA	2011	56
22272322	7124	Aaltonen KJ	Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.	PloS one	2012	43
22505457	7124	Harre U	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.	The Journal of clinical investigation	2012	97
22684480	7124	Swan C	Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.	Gut	2013	35
22884417	7124	Ganz PA	Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?	Brain, behavior, and immunity	2013	44
22887987	7124	Teo GS	Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms.	Stem cells	2012	33
22945416	7124	Raison CL	A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.	JAMA psychiatry	2013	174
23064634	7124	Dar RD	Transcriptional burst frequency and burst size are equally modulated across the human genome.	Proceedings of the National Academy of Sciences of the United States of America	2012	73
23095282	7124	Mäki-Petäjä KM	Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.	Circulation	2012	32
23103767	7124	Papantonis A	TNFα signals through specialized factories where responsive coding and miRNA genes are transcribed.	The EMBO journal	2012	34
23178294	7124	Vincent FB	Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective.	Annals of the rheumatic diseases	2013	33
23223420	7124	Garcês S	The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis.	Annals of the rheumatic diseases	2013	30
23267561	7124	Christy AL	Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.	Journal of autoimmunity	2013	28
23345452	7124	Paulsen MT	Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
23399692	7124	van Schouwenburg PA	Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis.	Nature reviews. Rheumatology	2013	35
23425071	7124	Aggarwal BB	Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.	British journal of pharmacology	2013	36
23649185	7124	Ford AC	Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.	The American journal of gastroenterology	2013	37
23735746	7124	Sandborn WJ	Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.	Gastroenterology	2014	87
23770005	7124	Sandborn WJ	Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.	Gastroenterology	2014	81
23792214	7124	Ben-Horin S	Optimizing anti-TNF treatments in inflammatory bowel disease.	Autoimmunity reviews	2014	31
23878167	7124	Steenholdt C	Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial.	Gut	2014	42
23993863	7124	Bhat KPL	Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.	Cancer cell	2013	159
24141950	7124	Jin F	A high-resolution map of the three-dimensional chromatin interactome in human cells.	Nature	2013	272
24291654	7124	Listing J	Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab.	Annals of the rheumatic diseases	2015	21
24382349	7124	Kagoya Y	Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.	The Journal of clinical investigation	2014	29
24388027	7124	Leise MD	Drug-induced liver injury.	Mayo Clinic proceedings	2014	41
24506179	7124	Stidham RW	Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis.	Alimentary pharmacology and therapeutics	2014	22
24718959	7124	Callhoff J	Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.	Annals of the rheumatic diseases	2015	22
24859203	7124	Sands BE	Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.	Gastroenterology	2014	38
24946050	7124	Gupta SC	Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols.	Archives of biochemistry and biophysics	2014	27
24968272	7124	Steyers CM 3rd	Endothelial dysfunction in chronic inflammatory diseases.	International journal of molecular sciences	2014	38
25165721	7124	Ozkok A	Pathophysiology of cisplatin-induced acute kidney injury.	BioMed research international	2014	35
25411043	7124	Monaco C	Anti-TNF therapy: past, present and future.	International immunology	2015	20
25422582	7124	Tuttolomondo A	Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.	Drug design, development and therapy	2014	23
25535390	7124	He X	Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
25562322	7124	Reissfelder C	Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.	The Journal of clinical investigation	2015	23
25825775	7124	Checco JW	Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
25897019	7124	Ben-Horin S	Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima.	Gut	2016	11
25986361	7124	Kolho KL	Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.	The American journal of gastroenterology	2015	15
26008591	7124	Brenner D	Regulation of tumour necrosis factor signalling: live or let die.	Nature reviews. Immunology	2015	66
26187233	7124	Ravussin E	A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	37
26282644	7124	Horvat TZ	Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.	Journal of clinical oncology 	2015	38
26582965	7124	Michielan A	Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.	Mediators of inflammation	2015	22
28264816	7124	Smolen JS	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.	Annals of the rheumatic diseases	2017	12
9389721	8842	Miraglia S	A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.	Blood	1997	204
14522905	8842	Singh SK	Identification of a cancer stem cell in human brain tumors.	Cancer research	2003	1201
15226377	8842	Richardson GD	CD133, a novel marker for human prostatic epithelial stem cells.	Journal of cell science	2004	184
15254585	8842	Torrente Y	Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle.	The Journal of clinical investigation	2004	87
15558321	8842	Florek M	Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.	Cell and tissue research	2005	73
16159812	8842	Bartunek J	Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.	Circulation	2005	104
17122772	8842	O'Brien CA	A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.	Nature	2007	1048
17205516	8842	Yin S	CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.	International journal of cancer	2007	149
17570225	8842	Ma S	Identification and characterization of tumorigenic liver cancer stem/progenitor cells.	Gastroenterology	2007	294
18172261	8842	Zeppernick F	Stem cell marker CD133 affects clinical outcome in glioma patients.	Clinical cancer research 	2008	157
18535813	8842	Bidlingmaier S	The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.	Journal of molecular medicine	2008	78
18560366	8842	Joo KM	Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.	Laboratory investigation; a journal of technical methods and pathology	2008	108
18654668	8842	Yang Z	Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice.	The Journal of clinical investigation	2008	73
18781171	8842	Horst D	CD133 expression is an independent prognostic marker for low survival in colorectal cancer.	British journal of cancer	2008	74
18802032	8842	Rappa G	The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma.	Stem cells	2008	65
18836486	8842	Baba T	Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.	Oncogene	2009	117
18941626	8842	Tirino V	Detection and characterization of CD133+ cancer stem cells in human solid tumours.	PloS one	2008	72
18985161	8842	Griguer CE	CD133 is a marker of bioenergetic stress in human glioma.	PloS one	2008	66
19047148	8842	Vander Griend DJ	The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.	Cancer research	2008	78
19092120	8842	Ronconi E	Regeneration of glomerular podocytes by human renal progenitors.	Journal of the American Society of Nephrology 	2009	147
19156211	8842	Mahller YY	Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.	PloS one	2009	51
19342601	8842	Barcelos LS	Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.	Circulation research	2009	64
19621338	8842	Horst D	The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.	The Journal of pathology	2009	47
19676044	8842	Salnikov AV	CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.	International journal of cancer	2010	53
19748175	8842	Zhang Q	A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.	Cancer letters	2010	50
19805294	8842	Bertolini G	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.	Proceedings of the National Academy of Sciences of the United States of America	2009	234
19816957	8842	Curley MD	CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.	Stem cells	2009	123
19904829	8842	Fan X	NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.	Stem cells	2010	191
20080668	8842	Pine SR	Microenvironmental modulation of asymmetric cell division in human lung cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	53
21220328	8842	Yan X	A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
21385990	8842	Tirino V	Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.	FASEB journal 	2011	49
21695188	8842	Kim MP	ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.	PloS one	2011	95
22079466	8842	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	49
22080056	8842	Zhang J	CD133 expression associated with poor prognosis in ovarian cancer.	Modern pathology 	2012	33
22431923	8842	Jamal M	The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.	Neoplasia	2012	33
22899341	8842	Grosse-Gehling P	CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.	The Journal of pathology	2013	75
23175471	8842	Sun YF	Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.	Hepatology	2013	68
23293278	8842	Bach P	Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.	Cancer research	2013	33
23409180	8842	Chen S	CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis.	PloS one	2013	30
23586700	8842	Alamgeer M	Cancer stem cells in lung cancer: Evidence and controversies.	Respirology	2013	37
24436149	8842	Sarvi S	CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.	Cancer research	2014	30
25262208	8842	Miranda-Lorenzo I	Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.	Nature methods	2014	30
25938772	8842	Hu Y	Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.	PloS one	2015	24
9861027	9429	Doyle LA	A multidrug resistance transporter from human MCF-7 breast cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	1998	354
9892175	9429	Miyake K	Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.	Cancer research	1999	122
11309308	9429	Maliepaard M	Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.	Cancer research	2001	184
11801536	9429	Kim M	The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.	Clinical cancer research 	2002	93
14576842	9429	Doyle L	Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).	Oncogene	2003	156
14612912	9429	Robey RW	Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.	British journal of cancer	2003	85
15251980	9429	Burger H	Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.	Blood	2004	74
15625123	9429	de Paiva CS	ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells.	Stem cells	2005	71
16024622	9429	Patrawala L	Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.	Cancer research	2005	271
16146333	9429	Mao Q	Role of the breast cancer resistance protein (ABCG2) in drug transport.	The AAPS journal	2005	80
17323127	9429	Robey RW	ABCG2: determining its relevance in clinical drug resistance.	Cancer metastasis reviews	2007	86
17510412	9429	Ho MM	Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.	Cancer research	2007	262
19506252	9429	Woodward OM	Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.	Proceedings of the National Academy of Sciences of the United States of America	2009	115
20368174	9429	Matsuo H	Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.	Science translational medicine	2009	72
20812902	9429	Ni Z	Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).	Current drug metabolism	2010	43
21625222	9429	Singh RR	ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.	Oncogene	2011	45
22498306	9429	Cheng W	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.	The FEBS journal	2012	60
25236865	9429	Mao Q	Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.	The AAPS journal	2015	33
12535572	10058	Schinkel AH	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.	Advanced drug delivery reviews	2003	198
14530494	10058	Leonard GD	The role of ABC transporters in clinical practice.	The oncologist	2003	141
16124856	10058	Dean M	Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.	Annual review of genomics and human genetics	2005	127
16305368	10058	Glavinas H	The role of ABC transporters in drug resistance, metabolism and toxicity.	Current drug delivery	2004	83
16842198	10058	Pérez-Tomás R	Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.	Current medicinal chemistry	2006	95
17006453	10058	Krishnamurthy PC	Identification of a mammalian mitochondrial porphyrin transporter.	Nature	2006	101
20004485	10058	Kis O	The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.	Trends in pharmacological sciences	2010	57
20447537	10058	Kalogeropoulos A	Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study.	Journal of the American College of Cardiology	2010	59
22246506	10058	Helias V	ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis.	Nature genetics	2012	32
22294766	10058	Hlavata I	The role of ABC transporters in progression and clinical outcome of colorectal cancer.	Mutagenesis	2012	36
23415156	10058	Tarling EJ	Role of ABC transporters in lipid transport and human disease.	Trends in endocrinology and metabolism	2013	40
14676194	10232	Rump A	Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.	The Journal of biological chemistry	2004	125
15217923	10232	Hassan R	Mesothelin: a new target for immunotherapy.	Clinical cancer research 	2004	123
15897581	10232	Ho M	Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.	Clinical cancer research 	2005	67
16061277	10232	Rosen DG	Potential markers that complement expression of CA125 in epithelial ovarian cancer.	Gynecologic oncology	2005	71
17067392	10232	Gubbels JA	Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.	Molecular cancer	2006	105
17945478	10232	Hassan R	Mesothelin targeted cancer immunotherapy.	European journal of cancer	2008	88
18088084	10232	Hassan R	Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.	Cancer immunity	2007	60
18281514	10232	Li M	Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.	Molecular cancer therapeutics	2008	53
22147941	10232	Le DT	A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.	Clinical cancer research 	2012	72
22351743	10232	Kelly RJ	Mesothelin-targeted agents in clinical trials and in preclinical development.	Molecular cancer therapeutics	2012	39
22371455	10232	Servais EL	Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.	Clinical cancer research 	2012	39
22412141	10232	Hollevoet K	Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.	Journal of clinical oncology 	2012	39
24334761	10232	Kachala SS	Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.	Clinical cancer research 	2014	29
24824231	10232	Pastan I	Discovery of mesothelin and exploiting it as a target for immunotherapy.	Cancer research	2014	46
24919573	10232	Moon EK	Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.	Clinical cancer research 	2014	46
24989332	10232	Hassan R	Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125.	Cancer	2014	34
26503962	10232	Morello A	Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors.	Cancer discovery	2016	35
16343244	10406	Bast RC Jr	New tumor markers: CA125 and beyond.	International journal of gynecological cancer 	2005	102
18061248	10406	Moore RG	The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.	Gynecologic oncology	2008	116
18851871	10406	Moore RG	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.	Gynecologic oncology	2009	117
19337252	10406	Huhtinen K	Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.	British journal of cancer	2009	49
20042715	10406	Anderson GL	Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.	Journal of the National Cancer Institute	2010	65
20368574	10406	Yurkovetsky Z	Development of a multimarker assay for early detection of ovarian cancer.	Journal of clinical oncology 	2010	71
20471625	10406	Moore RG	Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.	American journal of obstetrics and gynecology	2010	53
21304524	10406	Van Gorp T	HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.	British journal of cancer	2011	48
12563316	10544	Cheng T	Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.	Nature medicine	2003	145
12970121	10544	Esmon CT	The protein C pathway.	Chest	2003	112
15710622	10544	Finigan JH	Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.	The Journal of biological chemistry	2005	131
17299037	10544	Bae JS	Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	59
23741007	10544	Moxon CA	Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children.	Blood	2013	64
27185931	10544	Bernabeu M	Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass.	Proceedings of the National Academy of Sciences of the United States of America	2016	12
15743802	10630	Schacht V	Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.	The American journal of pathology	2005	112
17320377	10630	Monzani E	Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.	European journal of cancer	2007	159
16815144	10631	Takayama G	Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.	The Journal of allergy and clinical immunology	2006	127
17408641	10631	Erkan M	Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.	Gastroenterology	2007	81
17632525	10631	Kühn B	Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.	Nature medicine	2007	176
19010860	10631	Soltermann A	Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.	Clinical cancer research 	2008	74
19412434	10631	Erkan M	Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.	Neoplasia	2009	58
21593211	10631	Didangelos A	Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach.	Molecular and cellular proteomics 	2011	40
21812663	10631	Corren J	Lebrikizumab treatment in adults with asthma.	The New England journal of medicine	2011	268
22006671	10631	Gritsenko PG	Interstitial guidance of cancer invasion.	The Journal of pathology	2012	59
22246863	10631	Uchida M	Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2012	31
22535894	10631	Frangogiannis NG	Matricellular proteins in cardiac adaptation and disease.	Physiological reviews	2012	102
22857879	10631	Jia G	Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.	The Journal of allergy and clinical immunology	2012	93
23471469	10631	Hanania NA	Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.	American journal of respiratory and critical care medicine	2013	60
24075231	10631	Peters MC	Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.	The Journal of allergy and clinical immunology	2014	35
24247042	10631	Parulekar AD	Periostin, a novel biomarker of TH2-driven asthma.	Current opinion in pulmonary medicine	2014	25
25345775	10631	Underwood TJ	Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.	The Journal of pathology	2015	25
25422384	10631	Wagener AH	External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.	Thorax	2015	37
25580734	10631	Zhou W	Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.	Nature cell biology	2015	59
26747277	10631	McConnell JC	Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.	Breast cancer research 	2016	10
10359578	10673	Schneider P	BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.	The Journal of experimental medicine	1999	252
10398604	10673	Moore PA	BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.	Science	1999	235
11123269	10673	Zhang J	Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.	Journal of immunology	2001	140
11407690	10673	Cheema GS	Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.	Arthritis and rheumatism	2001	142
12427767	10673	Mackay F	BAFF AND APRIL: a tutorial on B cell survival.	Annual review of immunology	2003	198
12525388	10673	Mariette X	The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.	Annals of the rheumatic diseases	2003	86
12566413	10673	Scapini P	G-CSF-stimulated neutrophils are a prominent source of functional BLyS.	The Journal of experimental medicine	2003	81
12865416	10673	Avery DT	BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.	The Journal of clinical investigation	2003	99
14673998	10673	Stohl W	B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.	Arthritis and rheumatism	2003	86
15070697	10673	Moreaux J	BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.	Blood	2004	106
15353552	10673	Moir S	Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.	The Journal of experimental medicine	2004	75
15642740	10673	Krumbholz M	BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.	The Journal of experimental medicine	2005	67
15701725	10673	Sims GP	Identification and characterization of circulating human transitional B cells.	Blood	2005	133
16914324	10673	Bossen C	BAFF, APRIL and their receptors: structure, function and signaling.	Seminars in immunology	2006	82
16973390	10673	Enzler T	Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.	Immunity	2006	66
17433868	10673	Mackay F	B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.	Current opinion in immunology	2007	61
17942754	10673	Bossen C	TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.	Blood	2008	81
17947475	10673	Sarantopoulos S	High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.	Clinical cancer research 	2007	65
18668552	10673	Petri M	Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.	Arthritis and rheumatism	2008	70
19168788	10673	Sarantopoulos S	Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.	Blood	2009	86
19479852	10673	Yao Y	Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.	Arthritis and rheumatism	2009	88
19483719	10673	Doreau A	Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.	Nature immunology	2009	171
19521398	10673	Mackay F	Cracking the BAFF code.	Nature reviews. Immunology	2009	202
19561614	10673	Chen K	Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils.	Nature immunology	2009	76
20039404	10673	Jacobi AM	Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.	Arthritis and rheumatism	2010	45
20531452	10673	Pallier A	Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.	Kidney international	2010	54
20534450	10673	Cella M	Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity.	Proceedings of the National Academy of Sciences of the United States of America	2010	64
21097674	10673	Sarantopoulos S	Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.	Blood	2011	36
21482945	10673	Pellkofer HL	Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.	Neurology	2011	39
22124120	10673	Kreuzaler M	Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.	Journal of immunology	2012	43
22127708	10673	Furie R	A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.	Arthritis and rheumatism	2011	132
22736090	10673	Brkic Z	Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.	Annals of the rheumatic diseases	2013	28
23299618	10673	Yates NL	HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.	Mucosal immunology	2013	33
24018164	10673	Burger JA	The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.	Seminars in cancer biology	2014	39
25630041	10673	Wada NI	The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.	AIDS	2015	50
9828245	11093	Furlan M	von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.	The New England journal of medicine	1998	153
9828246	11093	Tsai HM	Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.	The New England journal of medicine	1998	158
12393397	11093	Dong JF	ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.	Blood	2002	166
12637323	11093	Vesely SK	ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.	Blood	2003	82
15801961	11093	Kokame K	FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.	British journal of haematology	2005	88
18574040	11093	Sadler JE	Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.	Blood	2008	64
18725999	11093	Yago T	Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.	The Journal of clinical investigation	2008	93
20032506	11093	Kremer Hovinga JA	Survival and relapse in patients with thrombotic thrombocytopenic purpura.	Blood	2010	64
20686117	11093	George JN	How I treat patients with thrombotic thrombocytopenic purpura: 2010.	Blood	2010	52
26025392	11093	Kelwick R	The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family.	Genome biology	2015	38
11278243	11096	Kashiwagi M	TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).	The Journal of biological chemistry	2001	103
17177994	11096	Bondeson J	The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.	Arthritis research and therapy	2006	75
17265492	11096	Song RH	Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.	Arthritis and rheumatism	2007	74
17430884	11096	Gendron C	Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.	The Journal of biological chemistry	2007	63
19915594	11096	Lin AC	Modulating hedgehog signaling can attenuate the severity of osteoarthritis.	Nature medicine	2009	81
21815191	11096	Verma P	ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.	Journal of cellular biochemistry	2011	35
21856929	11096	van Buul GM	Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes.	The American journal of sports medicine	2011	42
23602832	11096	Tian Y	Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-κB.	The American journal of pathology	2013	36
11567106	22914	Girardi M	Regulation of cutaneous malignancy by gammadelta T cells.	Science	2001	201
11861620	22914	Natarajan K	Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination.	Annual review of immunology	2002	88
14685277	22914	Moretta L	Unravelling natural killer cell function: triggering and inhibitory human NK receptors.	The EMBO journal	2004	114
15328155	22914	Carbone E	HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.	Blood	2005	71
16329186	22914	González S	Immunobiology of human NKG2D and its ligands.	Current topics in microbiology and immunology	2006	64
17202358	22914	Venkataraman GM	Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.	Journal of immunology	2007	60
17312110	22914	Draghi M	NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.	Journal of immunology	2007	65
17392508	22914	Cooley S	A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.	Blood	2007	79
17405908	22914	Cerboni C	Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.	Blood	2007	63
18490724	22914	Clayton A	Human tumor-derived exosomes down-modulate NKG2D expression.	Journal of immunology	2008	115
19201769	22914	Fisicaro P	Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.	Gut	2009	55
19470388	22914	Oliviero B	Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.	Gastroenterology	2009	115
19542445	22914	Hedlund M	Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.	Journal of immunology	2009	53
20080094	22914	Amadei B	Activation of natural killer cells during acute infection with hepatitis C virus.	Gastroenterology	2010	51
20103663	22914	Di Tomaso T	Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.	Clinical cancer research 	2010	57
20169160	22914	Spanholtz J	High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.	PloS one	2010	47
20519625	22914	Maniar A	Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.	Blood	2010	41
20536569	22914	Champsaur M	Effect of NKG2D ligand expression on host immune responses.	Immunological reviews	2010	155
21364924	22914	Hedlund M	Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells.	PloS one	2011	43
22102694	22914	Heinemann A	Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.	Cancer research	2012	41
22384114	22914	Nielsen N	Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.	PloS one	2012	31
22730533	22914	Hilpert J	Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.	Journal of immunology	2012	39
9461608	26762	Ichimura T	Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.	The Journal of biological chemistry	1998	236
11725301	26762	McIntire JJ	Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family.	Nature immunology	2001	111
17471468	26762	van Timmeren MM	Tubular kidney injury molecule-1 (KIM-1) in human renal disease.	The Journal of pathology	2007	100
19387469	26762	Vaidya VS	A rapid urine test for early detection of kidney injury.	Kidney international	2009	54
19572801	26762	Liangos O	Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass.	Biomarkers 	2009	56
19762491	26762	Hall IE	IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.	Journal of the American Society of Nephrology 	2010	81
20980978	26762	Vaidya VS	Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.	Kidney international	2011	54
21536871	26762	Kondratowicz AS	T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus.	Proceedings of the National Academy of Sciences of the United States of America	2011	100
22034509	26762	Hall IE	Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis.	Clinical journal of the American Society of Nephrology 	2011	37
24404151	26762	Shao X	Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis.	PloS one	2014	24
11799181	30835	Jameson B	Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques.	Journal of virology	2002	83
12515819	30835	Tailleux L	DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.	The Journal of experimental medicine	2003	138
12783086	30835	Navarro-Sanchez E	Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses.	EMBO reports	2003	126
15855154	30835	Lozach PY	Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.	The Journal of biological chemistry	2005	73
16177066	30835	Granelli-Piperno A	Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.	Journal of immunology	2005	70
16469696	30835	Pokidysheva E	Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.	Cell	2006	77
16951327	30835	Shreffler WG	The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro.	Journal of immunology	2006	63
18337571	30835	Rappocciolo G	Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.	Journal of virology	2008	61
19386588	30835	Martinez-Nunez RT	MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN).	The Journal of biological chemistry	2009	60
20484028	30835	Poschke I	Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.	Cancer research	2010	118
23416198	30835	Yu X	Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.	Journal of molecular biology	2013	25
12080485	54209	Paloneva J	Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.	American journal of human genetics	2002	134
23150908	54209	Jonsson T	Variant of TREM2 associated with the risk of Alzheimer's disease.	The New England journal of medicine	2013	372
23150934	54209	Guerreiro R	TREM2 variants in Alzheimer's disease.	The New England journal of medicine	2013	426
23318515	54209	Guerreiro RJ	Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.	JAMA neurology	2013	79
23380991	54209	Pottier C	TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.	Journal of Alzheimer's disease 	2013	33
23800361	54209	Rayaprolu S	TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.	Molecular neurodegeneration	2013	69
23855984	54209	Forabosco P	Insights into TREM2 biology by network analysis of human brain gene expression data.	Neurobiology of aging	2013	38
24119542	54209	Cuyvers E	Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.	Neurobiology of aging	2014	40
24139279	54209	Borroni B	Heterozygous TREM2 mutations in frontotemporal dementia.	Neurobiology of aging	2014	36
24355566	54209	Hickman SE	TREM2 and the neuroimmunology of Alzheimer's disease.	Biochemical pharmacology	2014	33
24535663	54209	Cady J	TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.	JAMA neurology	2014	55
24899047	54209	Jin SC	Coding variants in TREM2 increase risk for Alzheimer's disease.	Human molecular genetics	2014	32
24990881	54209	Kleinberger G	TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.	Science translational medicine	2014	85
25186950	54209	Lue LF	TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices.	Brain pathology	2015	19
6310399	94025	Bast RC Jr	A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.	The New England journal of medicine	1983	227
18468571	94025	Nossov V	The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?	American journal of obstetrics and gynecology	2008	61
19282241	94025	Menon U	Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).	The Lancet. Oncology	2009	169
20584542	94025	Friedlander M	A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer.	Gynecologic oncology	2010	41
20888993	94025	Rustin GJ	Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.	Lancet	2010	72
24081806	94025	Wu XS	Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.	Annals of surgical oncology	2014	21
24462730	94025	Williams KA	Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.	Gynecologic oncology	2014	26
25964255	94025	Menon U	Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.	Journal of clinical oncology 	2015	24
23001918	252995	Lecker SH	Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure.	Circulation. Heart failure	2012	35
23018146	252995	Huh JY	FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.	Metabolism	2012	127
23219488	252995	Stengel A	Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.	Peptides	2013	59
23369227	252995	Choi YK	Serum irisin levels in new-onset type 2 diabetes.	Diabetes research and clinical practice	2013	56
23436919	252995	Moreno-Navarrete JM	Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.	The Journal of clinical endocrinology and metabolism	2013	88
23619195	252995	Liu JJ	Lower circulating irisin is associated with type 2 diabetes mellitus.	Journal of diabetes and its complications	2013	59
23665283	252995	Zhang HJ	Irisin is inversely associated with intrahepatic triglyceride contents in obese adults.	Journal of hepatology	2013	29
24040023	252995	Raschke S	Evidence against a beneficial effect of irisin in humans.	PloS one	2013	52
24057291	252995	Park KH	Circulating irisin in relation to insulin resistance and the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2013	55
24062088	252995	Kraemer RR	A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women.	Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme	2014	23
24140091	252995	Polyzos SA	Irisin in patients with nonalcoholic fatty liver disease.	Metabolism	2014	26
24191966	252995	Hecksteden A	Irisin and exercise training in humans - results from a randomized controlled training trial.	BMC medicine	2013	28
24297848	252995	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	40
24506871	252995	Lee P	Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans.	Cell metabolism	2014	109
24709991	252995	Yan B	Association of serum irisin with metabolic syndrome in obese Chinese adults.	PloS one	2014	22
25514098	252995	Huh JY	Irisin in response to exercise in humans with and without metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2015	18
25749243	252995	Albrecht E	Irisin - a myth rather than an exercise-inducible myokine.	Scientific reports	2015	40
26278051	252995	Jedrychowski MP	Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry.	Cell metabolism	2015	42
28211512	252995	Perakakis N	Physiology and role of irisin in glucose homeostasis.	Nature reviews. Endocrinology	2017	7
16141795	283871	Wang D	Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C&amp;gt;T affects mRNA stability.	Pharmacogenetics and genomics	2005	89
18668431	283871	Zhou SF	Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.	Xenobiotica; the fate of foreign compounds in biological systems	2008	66
19309458	283871	Yang H	Functional expression and characterization of Arabidopsis ABCB, AUX 1 and PIN auxin transporters in Schizosaccharomyces pombe.	The Plant journal 	2009	52
23000902	283871	Jin MS	Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.	Nature	2012	105
23688078	283871	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	33
24155053	283871	Li J	Refined structures of mouse P-glycoprotein.	Protein science 	2014	57
1719635	100133941	Stefanová I	GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.	Science	1991	202
11121071	100133941	Uchida N	Direct isolation of human central nervous system stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2000	361
15709183	100133941	Abraham BK	Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.	Clinical cancer research 	2005	128
16885410	100133941	Sagrinati C	Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys.	Journal of the American Society of Nephrology 	2006	163
17020963	100133941	Balic M	Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.	Clinical cancer research 	2006	161
17053208	100133941	Lian Q	Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs.	Stem cells	2007	75
17229949	100133941	Liu R	The prognostic role of a gene signature from tumorigenic breast-cancer cells.	The New England journal of medicine	2007	282
17283135	100133941	Li C	Identification of pancreatic cancer stem cells.	Cancer research	2007	864
17349583	100133941	Shipitsin M	Molecular definition of breast tumor heterogeneity.	Cancer cell	2007	431
17588935	100133941	Pruszak J	Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations.	Stem cells	2007	87
17700640	100133941	Keller S	CD24 is a marker of exosomes secreted into urine and amniotic fluid.	Kidney international	2007	70
17900673	100133941	Runz S	Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.	Gynecologic oncology	2007	64
17978305	100133941	Lazzeri E	Regenerative potential of embryonic renal multipotent progenitors in acute renal failure.	Journal of the American Society of Nephrology 	2007	55
18241344	100133941	Wright MH	Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.	Breast cancer research 	2008	177
18268494	100133941	Hurt EM	CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.	British journal of cancer	2008	118
18366788	100133941	Fillmore CM	Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.	Breast cancer research 	2008	344
18559090	100133941	Honeth G	The CD44+/CD24- phenotype is enriched in basal-like breast tumors.	Breast cancer research 	2008	176
19264983	100133941	Chen GY	CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.	Science	2009	186
19437567	100133941	Choi D	Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.	World journal of gastroenterology	2009	51
19509181	100133941	Tanei T	Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.	Clinical cancer research 	2009	135
19619935	100133941	Theodoropoulos PA	Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.	Cancer letters	2010	71
19666588	100133941	Creighton CJ	Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.	Proceedings of the National Academy of Sciences of the United States of America	2009	405
19725119	100133941	Pruszak J	CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells.	Stem cells	2009	55
20027313	100133941	Hwang-Verslues WW	Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.	PloS one	2009	70
20079667	100133941	Blair PA	CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.	Immunity	2010	263
20103682	100133941	Park SY	Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.	Clinical cancer research 	2010	113
20190812	100133941	Gao MQ	CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.	Oncogene	2010	83
20405247	100133941	Giatromanolaki A	The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.	Medical oncology	2011	41
20521089	100133941	Blick T	Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.	Journal of mammary gland biology and neoplasia	2010	107
20691079	100133941	Bhat-Nakshatri P	SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.	BMC cancer	2010	61
20937839	100133941	Wu K	Cell fate determination factor Dachshund reprograms breast cancer stem cell function.	The Journal of biological chemistry	2011	35
20964822	100133941	Keller PJ	Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.	Breast cancer research 	2010	65
21067584	100133941	Louie E	Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.	Breast cancer research 	2010	47
21281815	100133941	Lindgren D	Isolation and characterization of progenitor-like cells from human renal proximal tubules.	The American journal of pathology	2011	53
21480217	100133941	Kryczek I	Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.	International journal of cancer	2012	70
21559013	100133941	Lee HE	An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.	British journal of cancer	2011	45
21633165	100133941	Marotta LL	The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.	The Journal of clinical investigation	2011	209
21726833	100133941	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	139
21835433	100133941	Idowu MO	CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.	Human pathology	2012	46
21882047	100133941	Zhang C	Identification of CD44+CD24+ gastric cancer stem cells.	Journal of cancer research and clinical oncology	2011	35
22308459	100133941	Meirelles K	Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22496457	100133941	Palafox M	RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.	Cancer research	2012	40
22565037	100133941	Cufi S	Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.	Oncotarget	2012	61
22610780	100133941	Meng E	CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.	Clinical and experimental metastasis	2012	37
22692575	100133941	Leth-Larsen R	Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.	Molecular medicine	2012	34
23124355	100133941	Smeets B	Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration.	The Journal of pathology	2013	36
23318426	100133941	Nishi M	Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.	Oncogene	2014	25
23427243	100133941	Flores-Borja F	CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.	Science translational medicine	2013	88
23644405	100133941	Wang F	Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay.	Gastroenterology	2013	49
24955581	100133941	Yang CH	Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma.	PloS one	2014	21
25051962	100133941	Khoder A	Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.	Blood	2014	41
25086633	100133941	Gwak JM	MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.	Breast cancer research and treatment	2014	26
25605369	100133941	de Masson A	CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.	Blood	2015	24
25823923	100133941	Qin L	WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.	Oncotarget	2015	19
26421710	100133941	Farnie G	High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.	Oncotarget	2015	22
11470825	100506658	Pálmer HG	Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.	The Journal of cell biology	2001	175
11733350	100506658	Kucharzik T	Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.	The American journal of pathology	2001	88
11801722	100506658	Gudjonsson T	Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.	Journal of cell science	2002	164
11914275	100506658	Gudjonsson T	Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.	Genes and development	2002	97
15236188	100506658	Cario E	Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.	Gastroenterology	2004	98
17916321	100506658	Chiba H	Transmembrane proteins of tight junctions.	Biochimica et biophysica acta	2008	66
19182773	100506658	Ploss A	Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.	Nature	2009	327
21146244	100506658	Zeisel MB	Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.	Journal of hepatology	2011	49
21294650	100506658	Carrano A	Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.	Antioxidants and redox signaling	2011	45
23357715	100506658	Vazquez-Roque MI	A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.	Gastroenterology	2013	56
23878165	100506658	Vivinus-Nébot M	Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.	Gut	2014	39
8901601	100507436	Groh V	Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.	Proceedings of the National Academy of Sciences of the United States of America	1996	197
9497295	100507436	Groh V	Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells.	Science	1998	214
10359807	100507436	Groh V	Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.	Proceedings of the National Academy of Sciences of the United States of America	1999	186
11491531	100507436	Steinle A	Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.	Immunogenetics	2001	91
12370336	100507436	Salih HR	Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.	Journal of immunology	2002	118
12384702	100507436	Groh V	Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.	Nature	2002	320
12414645	100507436	Pende D	Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.	Cancer research	2002	106
12714493	100507436	Salih HR	Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.	Blood	2003	100
12878725	100507436	Groh V	Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.	Proceedings of the National Academy of Sciences of the United States of America	2003	115
16024634	100507436	Armeanu S	Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.	Cancer research	2005	79
17218381	100507436	Nedvetzki S	Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.	Blood	2007	62
17495932	100507436	Kaiser BK	Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.	Nature	2007	80
17898098	100507436	Zou Y	Antibodies against MICA antigens and kidney-transplant rejection.	The New England journal of medicine	2007	70
18176566	100507436	Strid J	Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.	Nature immunology	2008	79
18202175	100507436	Jinushi M	MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.	Proceedings of the National Academy of Sciences of the United States of America	2008	64
18519766	100507436	Han LY	HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.	Clinical cancer research 	2008	55
18677316	100507436	Stern-Ginossar N	Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.	Nature immunology	2008	100
20068167	100507436	Ashiru O	Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.	Cancer research	2010	64
20212116	100507436	Chauveau A	Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
21262824	100507436	Xu B	Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
23444227	100507436	Srivastava RM	Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.	Clinical cancer research 	2013	66
23482656	100507436	Chen D	Genome-wide association study of susceptibility loci for cervical cancer.	Journal of the National Cancer Institute	2013	29
23679194	100507436	Chitadze G	Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.	Scandinavian journal of immunology	2013	29
25164008	100507436	Wang B	Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells.	Cancer research	2014	24
26041808	100507436	Lanier LL	NKG2D Receptor and Its Ligands in Host Defense.	Cancer immunology research	2015	40
